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ABSTRACT 
Background Ovulation is the central biological process involved in the 
menstrual cycle of women. Specifically, ovulation involves the tissue 
remodelling of the preovulatory follicle to achieve the rupture of the exterior 
follicle wall with the extrusion of the oocyte. Other important facets of 
ovulation include the expansion of cumulus cells around the oocyte, the 
resumption of the meiotic arrest of the oocyte, and the functional/structural 
reorganization of the rupturing follicle into a corpus luteum. The ovulatory 
process involves many mediators that cooperatively and redundantly carry out 
changes that are necessary for ovulation, normal progression and natural 
conception.  Increased knowledge of mammalian ovulation is important 
regarding many aspects of female fertility, such as the treatment of 
anovulation, ovarian stimulation in assisted reproduction, and the prevention 
of ovarian hyperstimulation. Another aspect is that it may lead to the 
development of new strategies for contraception.  
Aims: The general aim of this study was to increase knowledge regarding the 
intra-ovarian regulation of ovulation, which was achieved via studies on 
protease expression, the expression and regulation of the protease inhibitor, the 
proteome profile in follicular fluid, the expression of osteoprotegerin (OPG), 
the receptor activator of the nuclear factor kappa B ligand (RANKL), and the 
effects of calcineurin inhibitors on ovulation.  
Methods: Granulosa cells, theca cells, follicular fluid, and whole follicles were 
obtained from women at four different stages of the ovulatory process. 
Expression, proteome profile, and immunohistochemistry were performed. 
Granulosa lutein cells were used for the cell culture from women undergoing 
in vitro fertilisation (IVF). Immature Sprague-Dawley rats were primed with 
pregnant mare´s serum gonadotropin to induce maturation and subsequent 
ovulation, that was triggered 48 hours later with human chorionic gonadotropin 
(hCG). 
In vivo experiments in this animal model as well as in vitro experiments on its 
cells and tissues were conducted.  
Expression patterns were studied via a quantitative, real-time polymerase chain 
reaction (RT-PCR) and a microarray. Proteins were quantified and identified 
by mass spectrometry isobaric tags for relative and absolute quantification 
(iTRAQ), and localization was performed with immunohistochemistry. Assays 
were also used for the assessment of plasmin activity, leukocyte distribution, 
steroid levels, and levels of mediators / pharmacological agents in the blood. 
Results: Paper I indicate that an ovulatory trigger induces expression in the 
human granulosa and theca cells of certain proteases from the matrix 
metalloproteinase (MMP) as well as a disintegrin and metalloproteinase with 
thrombospondin-like motifs (ADAMTs) family. Paper II presents data on the 
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increased expression of the protease inhibitor tissue factor pathway inhibitor 2 
(TFPI2) in the ovulating follicle of the human and rat. Moreover, the down-
stream signalling pathways and effects on a large number of mediators were 
also characterized. Paper III use a modern proteomic technique to identify 
more than 500 proteins in the follicular fluid during ovulation, with 25 showing 
level changes during human ovulation. 
Paper IV identifies OPG and RANKL as potential mediators in the intra-
ovarian events of ovulation. Paper V demonstrates that cyclosporine-A, but not 
tacrolimus, negatively influences ovulation in the rat. 
Conclusion: The results of the thesis provide information on the roles and 
functions of several new mediators in ovulation. 
 
Key words: A disintegrin and metalloproteinase with thrombospondin-like 
motifs, animal model, calcineurin, cyclosporine-A, follicle, follicular fluid, 
granulosa cell, human, human chorionic gonadotropin, immunohistochemistry 
matrix metalloproteinase, menstrual cycle, osteprotegerin, ovary, ovulation, 
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Farnosh Zakerkish Sørensen 
vi 
 
MAPK mitogen-activated protein kinase 
MCP monocyte chemoattractant protein 
MEK mitogen-activated protein kinase kinase 
MMP matrix metalloproteinase 
MPO myeloperoxydase 
mRNA messenger ribonucleic acid 
NSAID non-steroidal anti-inflammatory drugs 
NRIP nuclear receptor interacting protein 
OHSS ovarian hyperstimulation syndrome 
OPG osteoprotegerin 
OPTN organ procurement and transplantation 
network 
OSE ovarian surface epithelium 
PA plasminogen activator 
PAI pa inhibitor 
PAR1 protease-activated receptor 1 
PI3K phosphatidylinositol 3-kinase 
PCOS polycycstic ovary syndrome 
PCR polymerase chain reaction 
PGA progesterone receptor a 
PGB progesterone receptor b 
PGF2α prostaglandin F2α 
PGR progesterone receptor 
PGRMC progesterone receptor membrane component 
PKA protein kinase a 
PKC protein kinase c 
PLAT tissue-type plasminogen activator 
PLAU urokinase-type plasminogen activator 
PMA phorbol-12-myristate-13-acetate 
PMSG pregnant mare serum gonadotropin 
PO preovulatory 
PON paraoxonase 
PR progesterone receptor 
Farnosh Zakerkish Sørensen 
vii 
 
PSO postovulatory 
PTGER prostaglandin e receptor 
PTGES prostaglandin e synthase 
PTSGS2 peroxidase/cyclooxygenase prostaglandin-
endoperoxide synthase 2 
RANK receptor activator of nuclear factor kappa B 
RANKL receptor activator of nuclear factor kappa B 
ligand 
RBC red blood cell 
rhCG recombinant human chorionic gonadotropin 
RPLPO large ribosomal protein 
RT reverse transcription 
RT-PCR real time polymerase chain reaction 
RUNX runt-related transcription factor 
SHBG sex hormone-binding globulin 
siRNA small interfering ribonucleic acid 
sOPG serum osteoprotegerin 
sRANKL soluble RANKL 
StAR steroidogenic acute regulatory protein 
SXC steric exclusion chromatography 
TAC tacrolimus 
TGF transforming growth factor 
TFP12 tissue factor pathway inhibitor 2 
TIMP tissue inhibitor of metalloproteinase 
TNF tumor necrosis factor 
TVU transvaginal ultrasound 
VEGF vascular endothelial growth factor 
v/v volume-to-volume ratio 

Farnosh Zakerkish Sørensen 
1 
 
INTRODUCTION 
During the fertile life of a woman, there exists several monthly cyclic events 
of the reproductive tract. The ultimate goal of these cyclic events in the woman 
is to develop a fertilizable oocyte, and then after fertilization by one sperm, 
provide optimal circumstances for embryo development, transport towards the 
uterus, implantation, placentation and further pregnancy. Within the ovary, 
ovulation is the central event after development of the oocyte and the ovarian 
follicle, and then culminates in the rupture of the follicle wall with the 
extrusion of a mature and fertilizable oocyte. The ovulatory follicle is invaded 
by leukocytes and functional as well as structural remodeling leads to 
formation of a corpus luteum. The present study deals with some of the 
intricate biochemical changes involved in the mechanism of ovulation. 
 
FOLLICULOGENESIS 
The mammalian primordial germ cells are derived from the embryonic 
ectoderm (Gardener et al., 1985) and are formed in the yolk sac wall. These 
germ cells migrate early in embryonic life into the evolving gonads, with 
continued mitotic divisions during migration and colonization of the primary 
gonad (Tam & Snow, 1981). In the primary gonad, the cells transform from 
ameboid into rounded shapes and are then named oogonia. Also, in this 
oogonial stage, there is a high mitotic activity (Beaumont & Mandl, 1962) with 
the cells located into clusters. The mitotic activity of this oogonial stage is 
exclusively during fetal life. Later on, onset of meiosis marks the transition of 
oogonia into oocyte and the initiation of this is by meiosis inducing substances 
(Andersen et al, 1981). Meiosis is arrested at the diplotene stage of the first 
meiotic division and this block of meiosis persists for variable periods of time, 
depending on when a follicle starts to grow. Around the periphery of a small-
sized oocyte (9-25 µm), there is a single layer of flattened pregranulosa cells 
and around that a basement membrane. These pools of non-growing primordial 
follicles are situated in the outer cortex of the ovary. In early human fetal life, 
there are about 7 million primordial follicles in the two ovaries together. There 
is a continuous and genetically determined non-gonadotropin dependent 
reduction in the pool of primordial follicles, and there exist around 400 000-
500 000 primordial follicles left at puberty (Gougeon, 1996). The development 
from this smallest follicle, the primordial follicle, into a preovulatory 
(Graafian) follicle is a long journey, with most of the primordial follicles 
undergoing apoptosis along the pathway towards the preovulatory follicle. The 
follicular development in human from a primordial follicle into a large 
preovulatory follicle takes about 120 days, as schematically shown in Fig. 1 
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Fig. 1. Schematic overview of follicular development in the human from a 
primordial follicle into a preovulatory follicle. 
 
The follicles are divided into preantral (all follicles form primordial until 
formation of a follicular antrum) and antral (follicles with fluid-filled antrum). 
The preantral follicles are characterized into three developmental stages 
(Lintern-Moore et al., 1974). The smallest is the primordial follicle (30-60 µm 
in diameter), that contains of a small oocyte (9-25 µm), which is surrounded 
by a layer of flattened pre-granulosa cells. The second type is the primary 
follicle (>60 µm in diameter), with also a small-sized oocyte (9-25 µm), but 
now with a change of pre-granulosa from flattened to cuboidal shape with 
proper granulosa cell appearance. The theca layer develops from interstitial 
stroma cells at the end of the primary follicle stage before transition into a 
secondary follicle. The third stage is the secondary follicle (> 120 µm in 
diameter), containing an enlarged oocyte (>60 µm) and with several layers of 
cuboidal granulosa cells, estimated to be > 500 in numbers and with some 
functional differentiation (Gougeon, 1996). These granulosa cells secrete 
mucopolysaccharides, which give rise to the zona pellucida (Chiquoine, 1960) 
of the oocyte and this facilitates gap junctional contact and transfer of 
biochemical information between granulosa cells and the oocyte. As the 
follicle grows, the theca externa forms. The appearance and the development 
of the theca layer are associated with follicular blood supply expansion. The 
overall development from primordial follicle to secondary follicle is 
gonadotropin independent, with influence from growth factors and cytokines 
(Findlay et al., 2002), such as transforming growth factor ß (TGF ß), bone 
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morphogenetic protein (BMP), and growth differentiation factor-9 (GDF-9) 
working in paracrine fashions (Liu et al., 2019). 
The follicular development phase that converts secondary and preantral 
follicles into antral follicles (>2 mm in diameter) is called the tonic growth 
phase. The differentiating secondary follicles migrate from the periphery of the 
ovary into the medulla and thecal arterioles are acquired (Bjersing & Cajander, 
1974c). Concurrent with the formation of capillaries, the theca-interstitial cells 
differentiate and start to express receptors for luteinizing hormone (LH) 
(Bacich et al., 1994) and show steroidogenic activity. 
These theca interna cells are epitheloid-shaped and located close to the 
basement membrane. The more peripheral layer of theca externa cells keep 
their spindle-shaped form and show a gradual merger with the stroma cells. 
The increase of LH and follicle stimulating hormone (FSH) in the human cycle, 
leads to recruitment of several growing follicles from the pool of preantral 
follicles and 5-10 follicles per ovary are commonly recruited each cycle. There 
is an increase in follicular diameter and high mitotic activity of granulosa cells. 
The overall increase in follicular size is due to the proliferation of the granulosa 
cells and the development of the follicular antrum. When the follicle is about 
0.2-0.4 mmm in diameter, several sites of accumulated fluid and spots with 
aggregated extra cellular matrix (ECM) are seen among the granulosa (van 
Wezel et al., 1999). A focimatrix also develops as aggregates of basal lamina-
like material between granulosa cells somewhat later during follicular 
development (Irving-Rodgers & Rodgers, 2005). The follicular antrum is then 
formed with accumulation of fluid and the follicle is transformed into a true 
antral follicle. In general, a preantral follicle develops into an antral follicle 
with formation of more granulosa cells and production of follicular fluid. The 
antral follicle will grow both by increase in volume of follicular fluid but also 
by increased number of granulosa cells. The follicular fluid contains also major 
blood proteins at approximately the same concentration as serum, but the 
relative proportion of proteins differs (Shalgi et al., 1973). These proteins reach 
the antrum by diffusion from the vascular spaces outside the basal membrane 
but there is also a large proportion of proteins that are produced within the 
granulosa cells, as elaborated on within the thesis. The development of the 
follicles and conversion into corpus luteum is outlined in Fig. 2 
  
Farnosh Zakerkish Sørensen 
4 
 
Fig. 2. Follicular development within the ovary. 
 
The cellular and extracellular arrangement of the preovulatory 
follicle  
The preovulatory follicle is made up of three separate functional units, which 
are the oocyte, the granulosa cell compartment, and the thecal cell 
compartment, as schematically shown in Fig 3 and described in detail below. 
The compartments contain different cell types and between that extracellular 
matrix (ECM), which supports the structure of the follicle but is also important 
for communication between cells within and between compartments.  
There are three phenotypically different granulosa cells in the preovulatory 
follicle. All granulosa cells are steroidogenically active with estradiol being 
their main product, but the different types of granulosa cells of the preovulatory 
follicle show disparate profiles of paracrine and autocrine signaling. The 
granulosa-cumulus cells enclose and support the oocyte, the antral granulosa 
cells are positioned adjacent to the follicular antrum, and the mural granulosa 
cells are next to the basement membrane, which is the structural barrier 
between the compartment of granulosa and theca cells.  
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Fig. 3. The different cells and layers of the preovulatory follicle. 
 
The theca cell compartment comprises a more centrally situated layer with 
theca interna cells, which are steroidogenically active and produce mainly the 
androgens, androstenedione and testosterone. In the functional unit of the 
preovulatory follicle, the two-cell cooperation is that of LH-stimulated 
androgen production in theca cells, diffusion of androgens into the avascular 
granulosa cell compartment, and conversion of androgens into estradiol, a 
process which is driven by FSH, stimulated induction of aromatase enzyme. 
The theca interna section has a thickness of around three to five cells in layers. 
There is also a vascular network of capillaries from the theca externa that 
reaches the theca interna. The more peripherally situated theca externa cells 
are non-steroid-producing cells. They are of two slightly different types. One 
sort resembles a fibroblast, and another is similar to a smooth muscle cell 
(Osvaldo-Decima, 1970; Fumagalli et al., 1971). 
The theca externa is a collagenous stratum with up to eight layers of fusiform 
cells and with extensive networks of blood and lymph vessels. Concerning the 
ECM composition of the theca layer, collagen type III is present in both the 
theca externa and the theca interna but is lacking in the basement membrane 
separating the theca interna from the granulosa cell compartment. Collagen 
type IV is found in both the theca interna and in the thecal-granulosa basement 
membrane (Lind et al., 2006).  
The tunica albuginea, outside the theca externa, is a dense layer of ECM that 
is positioned all around the periphery of the ovary. The tunica albuginea is 
composed of densely packed collagen fibers, surrounding a single layer of 
fibroblasts. The ECM of the tunica albuginea is composed of collagens type I, 
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type III, and type IV (Lind et al., 2006), and with collagen type I having 
concentric, network-like distribution. 
Above the tunica albuginea there is a basement membrane comprised primarily 
of laminin, enacting, and heparin sulfate proteoglycans (Espey, 1980, Murdoch 
& McDonnel, 2002, Yang et al., 2004). The outermost layer covering the 
preovulatory follicle is the single layer of ovarian surface epithelium (OSE), 
with cells that are flat or cuboidal, depending on stage of the reproductive cycle 
and position in relation to the preovulatory follicle.  
 
Structural and vascular alterations of the preovulatory follicle during 
ovulation 
There exist some studies that have looked at the structural changes of the 
preovulatory follicle at ovulation. An early study in the rabbit, using 
preovulatory follicles of different times during the ovulatory interval, showed 
typical patterns (Espey, 1971). Around two hours prior to rupture, the cells on 
the apex of preovulatory follicle become flattened and lose their microvilli 
(Motta et al., 1971). In some areas of the apex, the cells disappear completely, 
and large droplets of viscous fluid material collect on the surface (Motta & van 
Blerkom, 1975). Fibroblasts in the tunica albuginea and theca externa 
transform from quiescent to motile cells as they get elongated in shape.  
Further inside the follicle the mitotic activity among the granulosa cells 
decreases shortly after the LH surge (Boucek et al., 1967) and some of the 
granulosa cells come loose into the follicular antrum. Both theca cells and 
granulosa cells stop proliferating, enlarge in size and accumulate lipids into 
droplets that supply cholesterol for steroid hormone synthesis, as well as 
acquire of mitochondria with tubular cristae and large proportion smooth 
endoplasmic reticulum (Enders, 1973). In the theca externa there is a 
preovulatory increase in multivesicular structures in the fibroblasts and the 
possible release of enzymes from these may be related to the disintegration of 
the collagen fibers as ovulation approaches (Espey, 1971).  
There are also vascular changes that take place during the ovulatory process, 
and that is primarily in the theca layers. Within minutes after the gonadotropin 
surge, there is a rise in ovarian blood flow, caused by arteriolar dilation 
(Janson, 1975).  
Later there is an increase in vascular permeability (Kanzaki, et al., 1982). The 
increase in permeability is due to appearance of small fenestrations in the 
endothelium (Bjersing & Cajander, 1974b), and to the formation of gaps 
between the cells (Okuda et al., 1980). 
In a recent study this was quantified as a 3-fold increase in number of large 
pores during ovulation in the rat (Mitsube et al., 2013) interstitial edema 
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develops and with extravasation of erythrocytes (Parr, 1974) and leukocytes 
(Bjersing & Cajander, 1974c). The blood cells accumulate in the theca layer. 
Due to disruption of the basal membranes around the vessels and between the 
layers of theca cells and granulosa cells (Bjersing & Cajander, 1974b) fluid 
also collects among granulosa cells to increase the volume of follicular fluid 
in the antrum. This focal disruption of the basement membrane under the 
granulosa cells basal lamina, with local production of factors that stimulate 
neoangiogenesis cause ingrowth of capillaries into the previously avascular 
granulosa cell layer. Vessels, that grow from the theca and stromal vessels and 
towards the center of the follicle pushes into the granulosa cell layer so that an 
intersecting network will eventually contact every granulosa-lutein cell 
(Brannian et al., 1991). Vasoconstriction caused by soluble molecules such as 
endothelins may cause reduced blood flow through apical vessels (Migone et 
al., 2016). 
Along with expanding vasculature, increased blood flow and secretion of 
chemokines from theca and granulosa cells, induce a massive infiltration of 
leukocytes from circulating blood (Brännström & Enskog, 2002). The 
leukocytes with their machinery of active substances, including proteinases, 
will together with the resident cells of the preovulatory follicle cause a directed 
weakening of the follicular wall at the apex, leading to the rupture of the 
follicle when the gradually decreasing tensile strength of the follicle can no 
longer withhold the intra-follicular pressure (Matousek et al., 2001). 
 
THE HUMAN REPRODUCTIVE CYCLE 
The monthly reproductive cycle of the human is divided into the follicular 
phase, the luteal phase and between those the shorter ovulatory phase. 
Simultaneous changes occur in the endometrium and the ovary during the 
reproductive cycle. The two main phases of the endometrium are named the 
proliferative phase (corresponding to the ovarian follicular phase) and the 
secretory phase (corresponding to the ovarian luteal phase). The first day of 
menstruation (cycle day 1) is the start of the follicular phase and this phase 
usually has a length of 10-14 days, but with considerable inter-individual 
variations. 
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Deviations in total menstrual cycle length are most often due to variations in 
duration of follicular phase, since the duration of the luteal phase is fairly 
constant. Typically, the menstrual length becomes shorter towards the end of 
the fertile period. The hormonal changes during the follicular phase are shown 
in Fig.4.  
Fig. 4. Hormonal changes during the human menstrual cycle. E2 = 
estradiol; P4 = progesterone. 
 
There are elevated FSH levels during the first days of the follicular phase and 
this helps to stimulate recruited follicles that are engaged into each cycle. 
These recruited antral follicles are identical in their morphological appearance 
(Goodman et al., 1977, Nilsson et al., 1982) and around cycle-day 5, the 
processes of selection and dominance takes place (Pache et al., 1990). One 
follicle will during the midfollicular phase produce more estradiol than the 
other follicles and become dominant. It will show increased sensitivity for FSH 
and will also later gain of LH receptors. 
The dramatic increase of estradiol and inhibin A, produced by the dominant 
follicle, results in a negative feed-back regulation and FSH is decreased, which 
cause all the non-dominant follicles to go into atresia (Tilly et al., 1991). The 
dominant follicle is surrounded by theca cells that selectively bind more LH 
than the theca cells surrounding the non-dominant follicles (DiZerega et al., 
1980, Zeleznik et al., 1981). The estradiol levels will continue to rise despite 
decreasing FSH levels due to high androgen availability from the theca cells, 
a high sensitivity for FSH because of increased receptor density, and since the 
absolute number of granulosa cells increase rapidly due to marked mitosis 
among the cells. Moreover, vascularity in the theca of the dominant follicle 
becomes more prominent in comparison to other follicles (Kanzaki et al., 1981) 
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and this leads to increased delivery of LH to theca cells and FSH to the 
granulosa cells, also supporting further follicular growth and rising estradiol 
levels. This final phase of follicle development is therefore highly dependent 
on gonadotropins. The rising estradiol levels will prime the pituitary for the 
gonadotropin surge, where LH is the signal for ovulation. The regulation and 
effects of the LH surge are described in more detail below.  
The ovulation period is approximately 36 hours (h) long from the initiation of 
the LH surge until follicular rupture (Andersen et al., 1995, Hanna et al., 1994). 
There are prominent structural and functional changes in the follicle during 
this phase, as described above and below.  
After ovulation, the luteal phase starts, and the dominant follicle transforms 
into a corpus luteum with secretion of mainly progesterone but also estradiol. 
The changes in the steroidogenic machinery that allows this are described 
further in the section below. The secretion of these steroids results in a bell-
shaped concentration curve of progesterone and estradiol in peripheral blood, 
in the event of that implantation of an embryo does not occur. The duration of 
the non-pregnant luteal phase is fairly constant around 12-14 days duration and 
with luteolysis caused by prostaglandins (Dennefors et al., 1982, Vega et al., 
1998) and further invasion of macrophages (Lei et al., 1991, Wang et al., 
1992).  
 
The LH surge 
The midycle surge of LH is the initiator of the ovulatory events. The LH 
secretion is driven by gonadotropin releasing hormone (GnRH), a decapeptide 
of the arcuate nucleus of the hypothalamus that is released in pulses into the 
hypophyseal portal circulation. 
High and increasing blood levels of estradiol, as in the late follicular phase 
increase the frequency of GnRH pulses and prepare the gonadotropes 
(containing granules of LH) of the anterior pituitary to release large amounts 
of LH in response to each pulse of GnRH. This results in sustained high blood 
levels of LH for around 34 h in women (Casper, 2015). In the experimental 
setting and also commonly in vitro fertilization (IVF), human chorionic 
gonadotropin (hCG) is used as substitute for LH. It has a higher affinity to the 
LH/hCG receptor (LHCGR) than LH and is cleared more slowly from 
circulation, mainly because its higher content of saccharide chains (Norman et 
al., 2000). 
There are some differences in regional responsiveness to LH. While theca and 
granulosa cells of the preovulatory follicles express LHCGR, highest levels are 
present in theca and the mural granulosa cells closest to the basal lamina (Peng 
et al., 1991,Yung et al., 2014). Studies also show that LHCGR may be 
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expressed in focal areas around the ovulatory follicle, but in low density around 
the follicle apex (Nguyen et al., 2012).  
 
Second messengers of LH  
The complexity of the LH signaling pathway has been elucidated in greater 
detail during the last decades, from the original concept that cyclic adenosine 
monophosphate (cAMP), with interactions on protein kinase A (PKA), was the 
sole and second messenger for further downstream signaling after LH coupling 
to the G protein-coupled membrane receptor LHCGR. 
Thus other LH-induced intracellular signaling cascades in preovulatory follicle 
include protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K), tyrosine 
kinase-mediated pathways, and their respective downstream mitogen-activated 
protein kinases (MAPKs) (Panigone et al., 2008, Richards et al., 1979).  
The classical cAMP dependent way is by receptor activation of adenylate 
cyclase, causing increased levels of intracellular cAMP (Richards et al., 1979), 
leading to activation of the cAMP-dependent PKA to further activate the 
cAMP-response element-binding protein (CREB) (Richards et al., 1979). This 
intracellular signaling pathway is the primary pathway mediating LH action in 
the preovulatory follicle at ovulation. LH-activation of cAMP-PKA signaling 
pathway leads to very rapid activation of the epidermal growth factor receptor 
(EGFR)-tyrosine kinase pathway, as demonstrated by that hCG stimulates 
rapid and dramatic increases in (epidermal growth factor) EGF-like growth 
factors such as amphiregulin (AREG), epiregulin (EREG) and betacellulin 
(BTG) and also induces phosphorylation of EGFR in the preovulatory follicle 
( Panigone et al., 2008,Park et al., 2004,). Experiments with mutant mouse 
models have demonstrated the obligatory role of the activation of EGFR and 
their key downstream kinases, extracellular signalregulated kinase (ERK)1/2, 
in the ovulation, involving cumulus expansion, follicular rupture, and 
luteinization (Fan et al., 2009,Hsieh etal., 2007). 
Another pathway activated by LH is the PI3K pathway, shown by an effect to 
increase phosphorylation of protein kinase B (AKT) (Fan et al., 2008) and 
forkhead box protein O1 (FOXO1) Fan et al., 2008), both well-known 
signaling effectors downstream of the PI3K pathway. The binding of LH to 
LHCGR also activates member of the MAPK superfamily, including 
p38MAPK. Thus, hCG induced transient increases in p38MAPK 
phosphorylation in preovulatory rat follicles (Maizels et al., 2001) and there is 
a relationship with cumulus expansion since pharmacological inhibition of 
p38MAPK activity or genetic deletion of p38MAPKα isoform resulted in 
impaired meiotic resumption and cumulus expansion in porcine and mouse 
cumulus-oocyte complex (COCs) (Yamashita et al., 2009, Liu et al., 2010). It 
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has also been shown that LH increases inositol triphosphate levels in granulosa 
cells, suggesting activation of the PKC pathway (Davis et al., 1986). 
  
Transcriptional factors and regulation of post second messengers by 
luteinizing hormone (LH) 
Activation of the second messenger systems by LH, as described above, lead 
to activation/production of transcriptional regulators that directly control the 
transcription of downstream target genes. Concerning the classical nuclear 
progesterone receptor (PGR), it is known that two forms of PGR, denoted 
progesterone receptor A (PRA) and progesterone receptor B (PRB), are 
generated from the same gene via ribonucleic acid (RNA) splice variants 
(Kraus et al., 1993). In granulosa cells, expression of PRA predominates over 
PRB both before and after the LH surge (Shao et al., 2003). Distribution of 
PRA and PRB in theca cells has not been reported. The PGR is present in very 
low to nondetectable levels in granulosa cells of dominant follicles before the 
LH surge but expression increases rapidly after the LH surge (Shaffin et al., 
1999, Hild-Petito et al., 1988). 
Theca cells express modest levels of PGR before and after the surge (Horie et 
al., 1992). Membrane progesterone receptors also mediate progesterone action 
within the ovulatory follicle. These membrane receptors, progesterone receptor 
membrane component (PGRMC) 1 and PGRMC2, are progesterone binding 
proteins which cooperate with additional protein partners to generate a cellular 
response to progesterone (Peluso & Pru, 2014). The first indication of an 
obligatory role for PGR in ovulation was that progesterone receptor (Pgr) null 
mice fail to ovulate with oocytes remaining trapped within the newly formed 
corpus luteum (Robker et al., 2000). Early, it was found that the genes a 
disintegrin and metalloproteinase with thrombospondin-like motifs 1 
(Adamts1) and cathepin (Ctsl)  (Robker et al., 2000), coding for two proteases, 
are highly up-regulated by hCG, but markedly down-regulated in granulosa 
cells of ovulatory follicles in Pgr null mice. The proteases Adamts1 and Ctsl 
can act on ECM proteins to aid the breakdown of the follicular wall and it was 
later shown that Adamts1 deficient mice had compromised follicular 
development and ovulation (Shozu et al., 2005) and also effects on cumulus 
expansion. Recent gene profiling studies using Pgr null mice (Kim et al., 2008, 
Kim et al., 2009) have identified an array of PGR-downstream genes in 
granulosa cells of ovulatory follicles including the hypoxia-inducible factors 
HIF1A, HIF2A, and HIF1B.  
There is also an increased expression of CCAAT/enhancer-binding protein 
beta (CEBPB) transcription factors by an ovulatory signal in granulosa cells of 
preovulatory follicles in both rat and mouse (Park et al., 1991, Garcia et al., 
2012) and CEBPB null mice do not ovulate (Sterneck et al., 1997). Moreover, 
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administration of anti-sense oligos against CEBPB resulted in decreased 
ovulation rate in the in vitro perfused rat ovary (Pall et al., 1997). The use of 
conditional knockout mouse showed that the deletion of either 
CCAAT/enhancer-binding protein alpha (CEBPA) or CEBPB in granulosa 
cells resulted in reduced and deletion of both CEBPA and CEBPB induce 
complete blockade of the ovulatory events including cumulus expansion, the 
rupture of follicles, and luteinization (Fan et al., 2011).  
Core binding factor (CBF) is a heterodimeric transcription factor complex 
composed of α and β subunits, with the subunit encoded by one of three runt-
related transcription factor (Runx) genes (Runx1, Runx2, and Runx3) and the β 
subunit encoded by a single gene. 
Expression of Runx1 and Runx2 is rapidly induced in granulosa cells of 
preovulatory follicles by LH in humans (Park et al., 2010). Studies using rat 
granulosa cell cultures with small interfering ribonucleic acid (siRNA) 
identified several genes regulated by RUNX1 or RUNX2 including specific 
ovulatory genes and luteal genes (Park et al., 2012).  
Nuclear receptor interacting protein 1 (NRIP1) does not bind the 
deoxyribonucleic acid (DNA) directly but instead interacts with nuclear 
receptors to modulate transcriptional activity. The expression is highest in 
preovulatory follicles before the LH surge and nuclear receptor interaction 
protein 1 (Nrip1) null mice have defective ovulation and cumulus expansion, 
with effects on many genes involved in ovulation (White et al., 2000,Tullet et 
al., 2005).  
 
PARACRINE MEDIATORS IN OVULATION 
 
Steroids 
Prior to the LH surge, the mural granulosa cells begin to express LHCGR, to 
become responsive to the stimulatory actions of LH (Peng et al., 1991). 
Follicular fluid levels of estradiol are high before the LH surge (Andersen et 
al., 2006). After LH, granulosa cells then rapidly accumulate cholesterol-
containing lipid droplets, and there is enhanced expression of steroidogenic 
acute regulatory protein (StAR) and 3β-hydroxysteroid dehydrogenase 
(HSD3B1), which are involved in the early steps of steroidogenesis. Later, 
steps are low because of low expression of steroid 17α-monooxygenase 
(CYP17A1), so that conversion of progesterone to androgens and estrogens is 
severely limited (Chaffin et al., 1999, Weick et al., 1973, Wissing et al., 2014). 
Ovulatory follicles of humans produce both progesterone and 17α-hydroxy-
progesterone, which are both present at high concentrations in serum and in 
follicular fluid (Amin et al., 2014). Circulating levels of progesterone are very 
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low prior to the LH surge. Within minutes of the LH surge, serum progesterone 
levels increase, and follicular fluid levels of LH rapidly rise from nM to µM 
levels (Andersen et al., 2006). The action of progesterone and PGR activation 
on a large number of ovulatory mediators are described in other parts of the 
thesis.  
Administration of a progesterone synthesis inhibitor in macaque reduced 
structural luteinization and vascular remodeling in response to an ovulation 
trigger (Chaffin & Stouffer, 2000) which was restored. Replacement of 
progestin activity restored follicular angiogenesis (Chaffin & Stouffer, 2000). 
Moreover, the PGR antagonist mifepristone (RU486) reduced vascular 
remodeling associated with ovulation in pigs (Mauro et al., 2014). Besides, this 
steroid also has direct action on smooth muscle of the vasculature of the ovary 
(Press et al.,1988, Snijders et al.,1992,  Sahlin et al., 2006). 
Androstenedione is the predominant androgen from the ovulatory follicle.  
Androstenedione most often serves as a substrate for local production of 
estrogens and testosterone, with high androgen receptor (AR) affinity. The 
high concentrations of androstenedione suggest that this is also ligands for ARs 
in the ovulatory follicle. AR are present in both theca and granulosa cells 
before and after the LH surge (Horie et al., Hild-Petito et al.,1991). Optimal 
androgen concentrations appear to be critical for successful ovulation, with 
both high and low androgen levels causing ovulatory dysfunction (Walters et 
al., 2018). 
Androgens have also been implicated in control of microvascular dilation. 
Testosterone reduces the ability of subcutaneous vessels to dilate in response 
to endothelins (Wenner et al., 2013), but an effect of androgens on ovarian 
blood flow has not been directly demonstrated. 
A role for estrogen in human ovulation remains controversial. In the ovary, the 
two classical estrogen receptors (ESR), ESR1 and ESR2 are expressed, with 
ESR2 being the main type in granulosa cells (Choi et al., 2001). Gonadotropin-
driven ovarian follicular development, oocyte maturation, and fertilization 
were achieved in women with severely reduced estrogen synthesis due to 
specific enzyme deficits (Pellicer et al., 1991). However, reduction of 
nonhuman primate ovarian steroidogenesis by HSD3B inhibitor did not alter 
follicle development but caused ovulation failure and gave poorly fertilizable 
oocytes (Hibbert et al., 1996).  
 
Prostaglandins and leukotrienes   
Follicular levels of both prostaglandin E2 (PGE2) and prostaglandin F2α 
(PGF2α) increase in response to the LH surge (Duffy et al., 2005) and that is 
because increased expression of at least one form of every enzyme involved in 
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the synthesis of PGE2, including the phospholipase cytosolic phospholipase 
A2 (A2 PLA2G4A), the peroxidase/cyclooxygenase prostaglandin-
endoperoxide synthase 2 (PTGS2), and the prostaglandin E synthase (PTGES) 
(Duffy, 2015). Ablate-and-replace studies in nonhuman primates, identified 
PGE2 as the key ovulatory prostaglandin ( Duffy, 2015)and the four receptors 
four PGE2 receptors (PTGERs) are expressed by the primate ovulatory follicle, 
with an increase after LH (Kim & Duffy, 2016). The distribution is that of 
PTGER1 in mural granulosa cells and invading vascular endothelial cells, and 
of PTGER2 in mural granulosa cells near the rupture site, endothelial cells, the 
oocyte, and cumulus granulosa cells. The PTGER3 is found on mural 
granulosa cells and cumulus granulosa cells, while PTGER4 expression is 
limited but is detected in mural granulosa cells, the oocyte, and cumulus 
granulosa cells (Kim & Duffy, 2016). The role of prostaglandins in ovulation 
is mostly linked to regulation of ovarian blood flow (Murdoch & Myers, 1983) 
and in angiogenesis (Kim et al., 2014). This latter is mostly by PGE2 action 
via PTGER1 and PTGER2 receptors, as shown in assays of endothelial cell 
migration and capillary stalk formation (Trau et al., 2016, Kim et al., 2014).  
Leukotrienes are produced by the ovulatory follicle and follicular 
concentrations of leukotrienes increase rapidly after the LH surge (Espey et al., 
1989). 
Furthermore, a member of this class of eicosanoid is present in human 
follicular fluid (Heinonen et al., 1986). Administration of lipoxygenase 
inhibitors to rodents decrease ovulation rates in vivo (Gaytán et al., 2006) and 
in the in vitro perfused ovary (Mikuni et al., 1998). 
 
Vasoactive substances 
Bradykinin is a non-peptide, which together with other kinins are produced 
locally in the tissue from circulating kininogens. There is a preovulatory rise 
in kinin-forming enzymes, kallikreins, observed in the adult cycling rat (Smith 
& Perks, 1983b) as well as in the immature PMSG/hCG-primed rat (Espey 
etal., 1986). Moreover, addition of bradykinin markedly increases the number 
of LH-induced ovulations in the perfused rat ovary (Brännström & Hellberg, 
1989).  
There is a preovulatory decrease in the histamine concentration in rat ovaries 
(Szego & Gitin, 1964; Schmidt et al., 1988), which can be associated with a 
degranulation of ovarian mast cells (Jones et al., 1980). Further evidence for 
participation of histamine in ovulation is that histamine induces ovulations in 
the in vitro perfused rat (Schmidt et al., 1986) and rabbit (Kobayashi et al., 
1983) ovary. Histamine effects are likely on the ovary. 
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Growth factors 
The epidermal growth factor (EGF) family of proteins is essential for 
ovulation, most notably cumulus expansion (Russel & Robker, 2007)).  The 
EGF family includes proposed ovarian mediators such as amphiregulin 
(AREG) and epiregulin (EREG), the LH-surge stimulates a rapid increase in 
follicular expression of both AREG and EREG, identifying these proteins as 
likely paracrine regulators of ovulation (Park et al., 204). They activate 
epidermal growth factor receptors (EGFRs), located on both mural and 
cumulus granulosa cells (Park et al., 2004, Shimada et al., 2006).  
Members of the vascular endothelial growth factor (VEGF) family of growth 
factors are structurally-related and utilize the same group of receptors to 
mediate vessel growth and permeability. Vascular endothelial growth factor A 
(VEGFA) seems to have a role in ovulation since neutralization of VEGFA 
action within the follicle significantly disrupted ovulation in non-human 
primates (Wullf et al., 2002, Hazzard et al., 1999) and since there is a rapid 
increase in follicular fluid VEGFA levels after ovulation triggering as 
measured in women (Gutman et al., 2008)  and non-human primates (Hazzard 
et al., 1999, Gutman et al., 2008, Mauro et al., 2014, Chowdhury et al., 2010, 
Miyabayashi et al., 2005, Baskind et al., 2014). Furthermore, the LH surge 
increases VEGFA mRNA and protein in granulosa cells and follicular fluid, 
respectively (Miyabayashi et al., 2005, Baskind et al., 2014). 
Rodents lacking VEGFA expression in granulosa cells showed reduced 
ovulation rates and litter sizes (Sargent et al., 2015). The effect of VEGFA is 
likely to be through modulation of ovarian blood flow and transition into a 
corpus luteum (Fraser et al., 2000, Hazzard et al., 2002).  
A critical role for placental growth factor (PGF) in ovulation has also been 
demonstrated (Bender et al., 218) and the effect by blockage of PGF action 
seems to be on endothelial cell proliferation and capillary lengthening (Herbert 
& Stainier, 2011). This growth factor is present in human follicular fluid 
(Gutman et al., 2008). Messenger ribonucleicacid (mRNA) for the 
angiopoietins (ANGPTs), ANGPT1 and ANGPT2 are detected in granulosa 
and theca cells and the proteins are detectable in follicular fluid (Miyabayashi 
et al., 2005, Nishigaki et al., 2011). The ratio of ANGPT1/ANGPT2 protein in 
human follicular fluid is lowest in the largest and most mature preovulatory 
follicles ( Nishigaki et al., 2011), supporting the concept that this ratio favors 
ovulatory events. A functional role is indicated by that intrafollicular 
administration of a blocker of ANGPT2 reduced ovulation in the macaque (Xu 
et al., 2005).  
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Plasminogen activators 
Plasminogen activators (PAs) are selective serine proteases which convert 
plasminogen, an inactive zymogen present in high concentrations in most 
extracellular fluids including follicular fluid (Beers, 1975), into plasmin. 
The glycoprotein plasminogen is synthesized in the liver and plasminogen is 
enzymatically cleaved by PAs to form plasmin. Plasmin is a broad-spectrum 
serine protease that cleaves fibrin and fibrinogen as well as a variety of ECM 
proteins. These include collagen types III, IV, and VI, fibronectin, laminin, 
which are components of the ovarian follicle. Plasmin can also activate pro 
matrix metalloproteinases (pro-MMPs) by cleavage (Curry & Smith, 2006). 
There exist two main plasminogen activators, the urokinase-type plasminogen 
activator (PLAU) and tissue-type plasminogen activator (PLAT), being 
products of independent genes, but sharing similarities in their basic structures 
and physiological modes of action (Degen et al., 1986). Activation of the 
plasmin/PA system is started by release of PLAT or PLAU by cells in response 
to external signals such as hormones, growth factors, or cytokines and this 
leads to locally-restricted extracellular proteolytic activities as shown in 
ovulation in the macaque (Liu et al., 2004). 
There are several indications that PAs, are critically involved in ovulation. A 
large (3- to 14-fold) preovulatory increase in PA activity in rat ovarian 
homogenates is seen just prior to follicular rupture (Espey et al, 1985; Canipari 
& Strickland, 1985; Liu et al., 1987) and a localized increase in fibrinolytic 
activity over the stigma region was seen prior to ovulation in the rat (Akazawa 
et al., 1983). Gonadotropins decrease the activity of PA inhibitors in granulosa 
cells (Ny et al., 1985). Streptokinase, an exogenous PA, induces ovulation in 
the perfused rabbit ovary (Yoshimura et al., 1987), while the product of PA 
action, plasmin, decreases the tensile strength of incubated strips of the bovine 
follicle wall (Beers, 1975). 
 
Matrix metalloproteinases 
There are major alterations in the ECM during ovulation with main breakdown 
of structural ECM components in the top of the follicle and reorganization of 
ECM around other parts of the follicle. The matrix metalloproteinases (MMPs) 
and their associated endogenous inhibitors control the site and extent of this 
ECM turnover in and around the follicle and are linked to the ovulatory 
process. The MMP family is made up of more than 20 related proteolytic 
enzymes (Nagase & Hideaki, 1996, Murphy et al., 1999), divided into the 
subclasses collagenases, gelatinases, stromelysins, and membrane type 
enzymes (MT-MMPs).  The MMPs have several structural and functional 
similarities. There is a zinc in the active site of the catalytic domain. They are 
synthesized as inactive pro-enzymes with activation of the latent pro-MMP in 
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the extracellular space. They exhibit their action by site specific recognition by 
the catalytic domain of the enzyme, causing cleavage of a specific ECM 
protein. The MMPs are inhibited by both serum borne (macroglobulin) and 
tissue derived MMP inhibitors (TIMPs), and this action is important to restrict 
proteolytic action in time and in space. In the ovulatory follicle this will include 
early activation on the top of the follicle but protection from degradation at 
basal levels of the follicle. 
The collagenases (MMP1, MMP8, and MMP13) cleave both fibrillar collagens 
(collagen types I, II, III, V, XI) and nonfibrillar collagens (collagen types IX, 
XII, XIV). At MMP cleavage of collagen the collagen protein will denaturate 
and form gelatin, which is further degraded by the gelatinases (MMP2 and 
MMP9) and stromelysins (MMP3, MMP7, MMP10, MMP11). The gelatinases 
and stromelysins have action on the major constituents of basement 
membranes including type IV collagen, laminin, and fibronectin. An important 
function of MMPs in relation to ovulation is that they also exhibit activity on 
growth factors, and cytokines. The MMPs can cleave growth factors and 
cytokines of extracellular domains and thereby modulate their bioavailability 
during the ovulatory process. There exist four members, with tissue inhibitor 
of metalloproteinase (TIMP)1 preferentially binding MMP9 and TIMP2 
inhibiting MMP2. These two TIMPS are freely mobilized in the extracellular 
space, in divergence with TIMP3 which is bound to the ECM. In addition to 
the classical role to regulate MMP action, the TIMPs also have roles in 
regulation of steroidogenesis (Fassina et al., 2000), of embryo development 
(Satoh et al., 1994), and of angiogenesis agents (Johnson et al., 1994). There 
are several lines of evidence that MMPs are active in ovulation. The first 
scientific results on the action of MMPs in ovulation came from experiments 
that was conducted 30 years ago and included the methodology of the in vitro 
perfused ovary. Specific blocker of MMPs were able to significantly reduce 
the number of LH-induced ovulations in a rat ovary that was perfused ex vivo 
for several hours (Butler et al., 1991, Brännström et al., 1988). The concept of 
MMP action in the ovary has since then been expanded to several animal 
species including the primates (Peluffo et al., 2011). Action and role of MMPs 
and other proteases is one focus of the present thesis and this will be discussed 
further in the Discussion section.  
 
Proteases of a disintegrin and metalloproteinase with 
thrombospondin motifs (ADAMTS) 
The ADAMTS family are a class of 19 related and secreted 
metalloendopeptidases and are divided into seven subgroups based on 
similarities of action of the targeted substrates (Porter et al., 2005). The 
ADAMTS are synthesized as inactive pre-proenzymes and secreted. They have 
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diverse actions including degradation of proteoglycans such as aggrecan, 
brevican, and versican. Moreover, they can activate procollagens to collagen 
and can control the basement membrane remodeling (Blelloch et al., 1999, 
Nishiwaki et al., 2000). TIMPs can also regulate ADAMTS in the extracellular 
space as exemplified by the role of TIMP3 (Kashiwagi et al., 2001). There are 
studies in rodents that have clearly found a role for ADAMTS, especially 
ADAMT-1 in ovulation (Boerboom et al., 2003, Russel et al., 2003).  
Recent studies in the human have shown increased expression in of ADAMTs 
granulosa cells during ovulation and possible relationship with fertilization 
capacity (Yung et al., 2010) 
 
Leukocytes and chemokines in ovulation 
Several studies point towards the importance of invasion of leukocytes into the 
follicle at ovulation. Early studies showed addition of leukocytes to the in vitro 
perfused ovary increased LH-induced ovulation rate (Hellberg et al., 1991) and 
a depletion of neutrophils (Brännström et al., 1995) or macrophages (Van der 
Hoek et al., 2000) in vivo decreases ovulation rate in rats and mice, 
respectively. Studies in the rat could show a periovulatory increase in several 
leukocyte subsets in the follicle (Brännström et al., 1994) and this could later 
be verified in the human (Brännström et al., 1994). 
The leukocyte migration is via the classical four steps of rolling, activation, 
adhesion, and transmigration into the ovarian tissue. In the ovary, interleukin 
(IL)8 synthesis is induced in granulosa cells and theca cells to a large extent 
and rapidly after LH stimulation (Runesson et al., 1996). Increased IL8 
stimulates neutrophils to infiltrate the ovarian vascular permeability 
(Murayama et al., 210). Treatment with neutralizing antibodies to IL8 reduces 
ovulation and neutrophil invasion (Ujioka et al., 1998). Other important 
chemokines are chemokine (c-c motif) ligand (CCL)20 and chemokine (c-x-c 
motif) ligand 12 (CXCL12), which are induced in human granulosa cells and 
theca cells at ovulation (Al-Alem et al., 2015). A recent study in the rat details 
the sequential pattern of leukocyte influx into the ovulatory ovary (Oakley et 
al., 2010). By flow cytometry temporal changes in leukocyte populations in 
the ovaries of naturally cycling adults and immature rats during ovulation was 
characterized showing a massive influx of leukocytes at around half of the 
duration of the ovulatory interval (Oakley et al., 2010). Other important 
chemokines in the ovary are monocyte chemotactic protein-1 (MCP1), which 
is a potent chemoattractant for monocytes and it also effectively recruits 
macrophages and T-lymphocytes. Studies have shown that inhibiting the 
production of monocyte chemotactic protein-1 results in reduced ovulation 
(Cohen et al., 1997). Another chemokine which is likely to be active in 
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ovulation is CCL25, which inhibited leukocyte infiltration to the ovary and 
resulted in complete inhibition of ovulation in mice (Zhou et al., 2009). 
Ovarian CCL25 expression is firmly regulated by gonadotropins (Foster et al., 
210), and inhibition of ovulation failure was attributed to the lack of infiltration 
of a rare T cell population (Zhou et al., 2009, Zhou et al., 2005).  
The action of leukocytes in ovulation is most likely mediated through 
proteases. Leukocytes secrete MMPs in the preovulatory ovary (Fedorcsàk et 
al., 210) and granulosa cells and theca cells produce both MMPs and their 
tissue inhibitors (TIMPs) (Shalev et al., 2001, Stamouli et al., 1996, Goldman 
& Shalev, 2001). Collectively, this leads to digestion and weakening of the 
follicular wall, thereby contributing to rupture of the follicle.  
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AIMS 
The overall aim of this thesis was to study the mechanisms of intra-ovarian 
regulation at ovulation in order to increase the basic knowledge of this 
biologically important process.  
 
THE SPECIFIC AIMS WERE: 
 
PAPER I 
To characterize the expression patterns of certain matrix metalloproteinase 
(MMPs) and the disintegrin and metalloproteinase with thrombospondin-like 
motifs (ADAMTS) in the human follicle compartments of the theca and 
granulosa cells during human ovulation. 
 
PAPER II 
To assess the expression profile and regulation of tissue factor pathway 
inhibitor 2 (TFPI2) during ovulation in the human and the rat, as well as 
exploring the downstream effects on multiple ovulation-associated genes. 
 
PAPER III 
To identify for the first time by modern proteomic technique, which proteins 
in the human follicle, as mirrored by levels in follicular fluid are differentially 
regulated during the natural menstrual cycle. 
 
PAPER IV 
To explore the expression patterns of osteoprotegerin (OPG) and receptor 
activator nuclear factor kappa B ligand (RANKL) in granulosa and theca cells 
during human ovulation of the natural menstrual cycle. 
 
PAPER V 
To explore the effects of calcineurin inhibitors on ovulation rate, invasion of 
ovarian immune cells, and on expression of intraovarian modulators of 
ovulation in the rat. 
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PATIENTS AND METHODS 
Animal and human collection of samples 
 
Patients for obtainment of cells/tissue/fluid during ovulation of the 
natural menstrual cycle 
All women participating in the studies of papers I, II, III, and IV were 
monitored for obtainment of cells, tissue, and follicular fluid during ovulation 
of the natural menstrual cycle according to the schematic overview, in fig 5. 
Fifty women were initially included during the study period which extended 
over 36 months. Due to the strict inclusion criteria, 12 patients were excluded, 
reducing the number of participants to 38 premenopausal women undergoing 
surgery for tubal ligation. Of the 38 women participating in the study, 28 of 
the samples were used for analysis of expression patterns, profiles, and 
regulations of the intended study object, and 12 samples were used for 
immunohistochemistry. Twenty-eight women in study I were also included in 
papers II and IV and, of these, 15 were also included in paper III.  
 
Monitoring and follicle collection of cells/tissue/fluid of women during 
ovulation of the normal menstrual cycle 
Collection of follicular cells, tissue, and fluid in papers I, II, III, and IV were 
collected from women with previously proven fertility, regular menstrual 
cycles, and who had not undergone hormonal treatment for at least 3 months. 
To enable follicle collection at one of four phases, that is, pre-, early, late, or 
postovulatory, the women were monitored with repeated transvaginal 
ultrasounds for an average of two cycles.  
For those participating the pre-ovulatory phase, the surgery was performed 
before the luteinizing hormone (LH) surge when the dominant follicle was 
≥14mm and ≤17.5mm. To mimic the endogenous LH surge, an injection of 
recombinant human chorionic gonadotropin (rhCG) was given, and surgery 
was performed at varying lengths of time after the injection: early ovulatory 
phase (12 to ≤18 hours), late ovulatory phase (>12 to ≤ 34 hours) and 
postovulatory phase (>44 to ≤ 70 hours). This is illustrated in fig 6.  
The entire dominant follicle was excised from the ovary using scissors and 
placed inside a laparoscopic sac, which was retrieved through a suprapubic 
trocar incision. 
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Fig 6. Illustration of monitoring and follicle collection  
Follicle collection for cells/tissue/fluid of women during ovulation 
when undergoing in vitro fertilization (IVF) 
In paper I, women undergoing IVF were treated with gonadotropin-releasing 
hormone (GnRH) agonist and given recombinant follicle stimulating hormone 
(rFSH) to induce follicular growth. Recombinant human chorionic 
gonadotropin (rhCG) was administered when the two largest follicles had an 
average diameter of ≥18mm and, thereafter, granulosa-lutein cells were 
collected 34–36 hours post-rhCG administration by ultrasound-guided 
aspiration. 
 
Peripheral blood collection of women 
In paper IV, peripheral blood samples were collected from three groups of 
women to investigate possible variations. The subgroups were women with 
regular menstrual cycles, breastfeeding women, and postmenopausal women. 
Blood samples were retrieved every third day for 4 weeks, starting on the first 
day of menstruation in the group of women with normal menstrual cycles, and 
less frequently in the other two groups. 
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Figure 7. Flow-chart of exclusion of study participants in paper I, II, III 
and IV.  
n=50 Samples of tissues from women during ovulation 
of the natural menstrual cycle 
n=12  
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- Menstrual 
Irregularities 
- Ovulation 
 
n=38 Paper I 
Paper II 
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Rat ovarian tissue/cells and blood collection 
All the rats in the studies were maintained at room temperature with food and 
water provided ad libitum. 
In paper II, immature female Sprague-Dawley rats were purchased from 
Harlan, Indianapolis, IN. When the rats were 24 to 25 days of age, they were 
administered 10 IU of pregnant mare serum (PMSG). To induce ovulation, 5 
IU of human chorionic gonadotropin (hCG) was administered 48 hours after 
the PMSG injection. The rats were then euthanized at varying intervals after 
hCG treatment (0, 4, 8, 12, and 24 hours) for tissue collection. Whole, intact 
ovaries were used, as well as isolate granulosa cells and residual ovarian tissue. 
The residual tissue represents the ovarian tissue left behind after granulosa cell 
collection and is a heterogeneous tissue. The ovaries collected at defined time 
points after hCG were punctured with a 26-gauge needle to release the 
granulosa cells for collection. The residual ovarian tissue left over was 
removed, and granulosa cells were partially purified by filtration through a 40-
µ pore size nylon filter and pelleted by centrifugation at 300 x g. This was done 
to remove tissue debris and cumulus-oocyte complexes (COCs). Tissues 
collected for messenger ribonucleic acid (mRNA) analysis were frozen and 
stored at -70°C for analysis. 
In paper V, immature female Sprague-Dawley rats were purchased from 
Harlan, Horst, Netherlands, weighed at the age of 21 days, and allocated to 
three different groups: group 1 control with sodium chloride (0.9% NaCl), 
group 2 cyclosporin A (CyA), and group 3 tacrolimus (TAC). 
When the rats were 24 to 25 days of age, they were administered 10 IU of 
equine chorionic gonadotropin (eCG). To induce ovulation, 10 IU of hCG was 
administered 48 hours after eCG injection. The rats were then euthanized 20 
hours after hCG treatment for tissue collection. 
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Calcineurin inhibitors administration 
In paper V, mini-osmotic pumps were filled with a solution tacrolimus (TAC), 
cyclosporine-A (CyA), or control according to each animal’s weight. Two 
different pump models were used with identical external composition. The 
pumps were primed in NaCl at 37°C 12 hours prior to insertion, according to 
the manufacturer´s instruction. Postnatal day 21, under isoflurane anesthesia, 
a skin incision was made in the back of each animal caudally to the neck and 
the pump placed subcutaneously in a parasagittal position. The skin was 
subsequently closed with two polyglactin stitches. 
 
Cell cultures and cell experiments 
In vitro fertilization (IVF) granulosa-lutein cells 
In paper I, the oocyte was removed from the follicular aspirate in women 
undergoing IVF, and follicular aspirates were pooled from multiple follicles of 
the same patient and placed in OptiMEM I media. To separate the red blood 
cells from the granulosa-lutein cells, Percoll gradient centrifugation was used. 
The aspirates were pelleted by centrifugation and resuspended in 1ml of 
OptiMEM I media. The isolated granulosa-lutein cells were then cultured in 
OptiMEM media containing 10% fetal Bovine serum for 6–7 days. The media 
was changed every 24 hours. This allowed the cells to regain responsiveness 
to human chorionic gonadotropin (hCG) after being desensitized by the 
ovulatory dose of hCG. These cells were serum starved for 1 hour and then 
treated with or without hCG and collected at 6, 12, and 24 hours to examine 
expression of matrix metalloproteinase (MMP) and the a disintegrin and 
metalloproteinase with thrombospondin-like motifs (ADAMTs), in human 
granulosa-lutein cells from women undergoing IVF.  
HGL5 cell experiment  
HGL5 cell line in paper I is a virally transformed luteinized granulosa cell line 
that overcomes cell variability in human granulosa cells. HGL5 cells were used 
to examine the regulation of the desired proteins, such as matrix 
metalloproteinase (MMP) and the a disintegrin and metalloproteinase with 
thrombospondin-like motifs (ADAMTs) in the study. The cells were cultured 
in Dulbecco’s Modified Eagle’s Medium (DMEM)/F12 medium and 
supplemented with 10% ultralow IgG fetal bovine serum, 1% insulin-
transferrin-selenium (ITS), 1% Pen-Strep and 10 mg/mL gentamicin. The 
HGL5 cells were then plated in 12-well plates at a density of 1.5 x 105 
cells/mL/well, serum starved for 1 hour, and then treated with or without 
forskolin (FSK) plus phorbol-12-myristate-13-acetate (PMA) and collected at 
6, 12, and 24 hours.  
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Cell viability  
In paper II, granulosa cell viability was assessed by using a colorimetric 
method for determining the number of viable cells. The assay was performed 
with addition of CellTiter Aqueous One Solution Reagent directly to culture 
wells and incubated for 4 hours before quantification, according to the 
manufacturer’s instructions. 
Rat granulosa cell culture 
In paper V, immature rats were treated with pregnant mare serum (PMSG). 48 
hours after the treatment, the ovaries were collected and punctured. 
Preovulatory granulosa cells were isolated by follicular puncture of the ovaries 
and used for cell culture experiments. Isolated granulosa cells were cultured at 
5 x 10´5 cells/well in a 12-well tissue culture plate in OptiMEM media 
containing insulin-transferrin-selenium (ITS) and gentamicin. Thereafter, the 
cells were treated with or without human chorionic gonadotropin (hCG) for 
different durations of time (0, 4, 8, 12 and 24 hours). Both the conditioned 
culture media and cells were collected for hormone assay or ribonucleic acid 
(RNA) analysis. 
 
Chemical laboratory analysis 
Microarray analysis  
In paper II, granulosa cells from rats were cultured for small interfering 
ribonucleic acid (siRNA)-mediated knockdown of tissue factor pathway 
inhibitor 2 (TFPI2). Ribonucleic acid (RNA) from rat granulosa cells was 
transfected with TFPI2 siRNA or negative control siRNA, and then treated 
with forskolin (FSK) and phorbol-12-myristate-13-acetate (PMA) for 6 hours 
before microarray analysis. The integrity of the riboprobe was confirmed by 
gel electrophoresis.  
The Affymetrix GeneChip Rat Gene 2.0 ST oligonucleotide array was 
hybridized, washed, and scanned according to the manufacturer’s protocol. 
The changes observed by deoxyribonucleic acid (DNA) microarray analysis 
was confirmed by real-time polymerase chain reaction (PCR) for a select 
subset of genes. 
Steroid immunoassay 
In paper II, progesterone (P) in the conditioned media was assayed using an 
Immulite kit on an IMMULITE 1000, which uses enzyme amplified 
chemiluminescent technology. In this process, a stable chemiluminescent 
substrate is hydrolyzed by alkaline phosphatase and results in the production 
of the unstable adamantly dioxetane anion that gives rise to emission of light, 
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which is quantified by using an Immulite luminometer. Assay sensitivity was 
0.2ng/ml, and the intra-assay and inter-assay coefficients of variations were 
6.3% and 9.1% respectively.  
Enzyme-linked immunosorbent assay (ELISA) 
In paper IV, the levels of osteoprotegerin (OPG) and receptor activator nuclear 
factor kappa B ligand (RANKL) in serum were measured by use of 
commercially available polyclonal antibody-based sandwich ELISA technique 
according to the manufacturer’s instructions. The assay utilizes the two-site 
sandwich technique with two selected antibodies that bind to human serum 
OPG and RANKL. Briefly a monoclonal anti-human antibody was coated onto 
the inner surface of polystyrene microtiter wells, then a biotin-labeled 
polyclonal anti-OPG or anti-RANKL antibody was added. An enzyme-labeled 
streptavidin was added to the wells after overnight incubation, in order to 
selectively bind to the complexed biotin. A chromogenic substrate was used to 
develop color, and the absorbance noted in a microtiter plate reader. The intra-
assay and inter-assay variability were 8% and <10% for serum OPG, and 0.9% 
and 9.3% for serum RANKL. 
Proteomics 
As opposed to analyzing the entire proteome, the functional proteomics allow 
for the analysis of target proteins. Protein identification and characterization 
has meaningful outcomes, as these are usually driven by a specific biological 
question. In paper III, 50 ml of all follicular fluid (FF) samples were filtered. 
BCA assay was used to determine the concentration of proteins. The 
Qproteome Albumin/immunoglobulin G (IgG) Depletion Kit depleted human 
albumin and IgG. Thereafter, BCA assay was used again. ProteoExtract® 
Protein Precipitation were used to remove non-protein impurities. 
Pellets were then dissolved in iTRAQ® (Isobaric Tags for Relative and 
Absolute Quantification) dissolution buffer with addition of 1µl 2% sodium 
dodecyl sulfate and the samples reduced, alkylated, and digested with trypsin. 
The patient samples were then labeled with the iTRAQ reagents following the 
manufacturer’s instructions. The iTRAQ sets were then acidified with 10% 
formic acid and diluted with steric exclusion chromatography (SCX) 25mM 
ammonium formate, pH 2.8, 20% acetonitrile (ACN), and loaded onto a SCX 
column.  
The SCX chromatography and fractionation were carried out on a purifier 
system at 0.25mL/min flow rate. Fractions were collected at 0.5mL intervals 
and dried under vacuum while ultraviolet absorbance at 254 and 280 nm was 
monitored. The peptide containing fractions were desalted on PepClean C18 
spin columns according to the manufacturer’s instructions.  
Farnosh Zakerkish Sørensen 
28 
 
The fractions were reconstituted into 0.1% formic acid and analyzed on an 
LTQ-Orbitrap XL with an in-house constructed LC setup. 2µL sample 
injections were made with an HTC-PAL autosampler and connected to an 
Agilent 1200 binary pump. The peptides were trapped on a precolumn and 
separated on a reversed phase column. Both columns were then packed with 
3µm Reprosil-Pur C-AQ particles. The flow through the analytic column was 
reduced to 100 nl/min. One mass spectrometry scan was followed by CID 
(collision induced dissociation) and HCD (high energy collision dissociation) 
MS2 scans were performed of the three most abundant doubly or triply 
protonated ions of each scan. 
Proteome Discoverer version 1.1 was used for relative quantification and 
identification of all 10 SCX fractions for each 4-plex iTRAQ sets. Mascot was 
used for database searches of all sets and performed against Swiss-Prot version 
57.15. The identified proteins were grouped based on the same sequences to 
minimize redundancy, and the protein identification threshold was set to 95% 
confidence.  
To calculate fold changes between samples, iTRAQ raw data sets from the 
ratios of iTRAQ reporter ion intensities in MS/MS spectra were used. Ratio 
were derived by using the Proteome Discoverer version 1.1. Only peptides 
that were unique for a given protein were used for relative quantification as 
seen in fig 7.  
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Figure 7. Experimental overview of the mass spectrometry (MS) based 
method using the iTRAQ technology.  
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Plasmin assay  
In paper II, two different methods were used to assess plasmin activity; one 
method was by fluorimetric activity, and the other method was employed by 
utilizing the ability of the plasmin to cleave fibrinogen. Conditioned media 
from rat granulosa cell cultures were concentrated by centrifugation at 7,500g 
for 20 min and used in the activity assay. The total protein in the conditioned 
media was determined using a BioRad detergent compatible protein assay kit, 
as recommended by the manufacturer.  
To undergo fluorometric assay, the conditioned media of approximately 1 µg 
total protein and the fluorogenic peptide substrate were incubated for 60 
minutes at room temperature. By doing this, the enzymatic action of the 
plasmin on the substrate released a fluorophore (7-amido-4-
trifluoromethylcoumarin). The fluorescent signal was then measured using a 
spectrophotometer.  
The fibrinogenolytic assay was carried out with 10 µg of human fibrinogen 
being incubated in 10 mM tris (hydroxymethyl) aminomethane HCl in the 
presence of human plasmin (1U) or granulosa cell-conditioned media (1µg 
total protein) at 37℃ for 2 hours. Human plasmin plus fibrinogen were 
incubated with and without the plasmin inhibitor D-VAL-Phe-Lys-CMK 
(chloromethyl ketone dihydrochloride; 1µM) in order to assess the specificity 
of plasmin cleavage of fibrinogen. The reaction was stopped using a denaturing 
loading buffer containing 2.4 M urea. Thereafter, the reaction mixture was 
boiled and separated on 10% sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. The fibrinogenolytic products were then visualized by staining 
the gel with Coomassie blue. 
Calcineurin inhibitors level 
In paper V, 250µl of whole blood were drawn from the rat aorta at euthanasia. 
Tacrolimus (TAC) levels were measured by chemiluminescent immunoassay 
(CMIA). Cyclosporine-A (CyA) levels were measured by enzyme 
immunochemistry using a CyA-specific assay, according to the manufacturer’s 
instruction. 
Quantitative real-time polymerase chain reaction (RT-PCR) 
RT-PCR was used in papers I, II, IV, and V, Trizol Reagent Invitrogen was 
used to isolate the total ribonucleic acid (RNA) from granulosa, theca, 
granulosa lutein, and HGL5 cells, according to the manufacturer’s protocol. 
Using Taq-Man methodologies, the messenger ribonucleic acid (mRNA) 
expression levels for the desired proteins were analyzed by RT- PCR. 
Mx3000P QPCR system was used to perform the polymerase chain reaction 
(PCR) reactions in papers I and II, and the ABI Prism 7000 Sequence Detection 
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was used in papers IV and V. 2-∆∆𝐶𝐶t method was used to calculate the relative 
amount of mRNA in each sample and then normalized.  
 
 
Microscopic assessment 
Ovulation rate assessment and ovarian preservation 
In paper V, the ovulation rate was assessed 20 hours after the human chorionic 
gonadotropin (hCG) injection. After dissection, the left ovary was kept in RNA 
later and stored immediately at -20°C. The right ovary was kept in 4% 
formaldehyde. The ampullary regions of the fallopian tubes were then opened 
to release oocytes. The oocytes were incubated with hyaluronidase for ten 
minutes over a glass microscope slide in order to be scattered. Then, they were 
covered with a coverslip and counted under a Nomarski interference 
microscope. 
White blood cells subpopulation in peripheral blood 
In paper V, the rat aorta was punctured at euthanasia to obtain whole blood. 
The blood was spread onto a glass slide and air dried. It was then fixed by 
immersion in Romanowsky stock solution for 5 minutes and rinsed in distilled 
water and air dried again. The cells were then identified according to their 
specific characteristics by microscopic assessment. 
Immunohistochemistry  
Immunohistochemistry was used in papers I and V. Intact follicles were fixed 
in 4% paraformaldehyde overnight, embedded in paraffin, and sectioned for 
immunohistochemistry. Sections were deparaffinized, dehydrated, rinsed in 
sterile water, and then treated to block endogenous peroxidase activity. 
Sections were then incubated with antibodies for the desired proteins studied, 
washed, and incubated with a secondary antibody. The sections were treated 
with a conjugated streptavidin alkaline phosphatase to amplify the reaction 
signal and visualized by the Vulcan Fast Red Chromogen Kit, counterstained 
with hematoxylin and Permount Mounting Media in paper I and x400, Leica 
DM4000B in paper V.   
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Statistical Analysis  
 
PAPER I 
Kruskal-Wallis test and post hoc comparisons were performed using Dunn’s 
multiple comparison test or Tukey’s; p-value of <0.05 was considered 
statistically significant. 
Student’s t-test was used for additional analysis. 
PAPER II 
Bartlett’s 𝑥𝑥2 test was used to check for heterogeneity of variance and, 
thereafter, Bonferroni post hoc test and Bonferroni´s multiple comparison tests 
were performed. 
PAPER III 
Values between pre-ovulatory and ovulatory phases were analyzed using 
unpaired student´s t-test, and a p-value of <0.05 was considered statistically 
significant. 
PAPER IV 
Kruskal-Wallis and Mann-Whitney tests were performed to test for significant 
differences between groups. P-value of <0.05 was considered statistically 
significant. 
PAPER V 
Kolmogrov-Smirnoff test was used to test for normal distribution. Student t-
test or Mann-Whitney test were used to compare between groups. P-value 
<0.05 was considered statistically significant. 
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RESULTS AND COMMENTS  
The results of Papers I-V are summarized and commented upon in this section 
 
Results and comments for Paper I 
The human ovulatory process is a complex biological course of action that 
involves several mediator systems, which, in a partly repetitive fashion, causes 
the rupture of the follicle with the release of a fertilizable oocyte. The major 
structural strength of the follicle is given by the extracellular matrix (ECM), 
which is distributed in its outer layers. The two basement membranes, 
underlying the theca interna and the ovarian surface epithelium, are made up 
of collagen type IV and laminin.  In the theca layer of the follicle, collagen 
type III is the predominant ECM component in addition to collagen type I in 
the external theca layer. Collagen type I and III are also the major ECM 
components in the parts of the ovarian stroma and tunica albuginea that are 
between the preovulatory follicle and the exterior.  
All these collagen-rich structures must be breached, as the follicle ruptures and 
allows an oocyte to pass through from its antrum, through the layers of 
granulosa cells and theca cells, and onto the surface of the ovary.  
There exists a large amount of data regarding the specific proteinases that are 
active in the breakdown of the wall of the preovulatory follicle in animal 
species, mostly rodents. However, the literature on this subject is limited 
regarding human ovulation. There is human data from cell-culture experiments 
available, but these studies have all utilized human granulosa-lutein cells 
obtained from in vitro fertilization (IVF) cycles. These cells come from an 
artificial hyperstimulated cycle, and it is questionable whether the physiology 
of these cells will mimic the normal situation. 
The present study is one of the first to examine proteinase expression in the 
human ovulatory follicle of the natural menstrual cycle. Moreover, the study 
focused on the expression and regulation of the proteinase matrix 
metalloproteinases (MMPs) and a disintegrin and metalloproteinase with 
thrombospondin motifs (ADAMTs) in human ovulation. Expressions before 
and during different intervals of ovulation were compared, and comparisons 
were also made between the two major cell compartments of the follicle: the 
theca compartment and the granulosa compartment. Expression was evaluated 
via a quantitative reverse transcription polymerase chain reaction (RT-PCR). 
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Results 
During the early ovulatory phase, 12 to18 hours after the triggering of 
ovulation, the expression of several proteinases increased in both the granulosa 
cells and theca cells. Thus, MMP19, MMP 1, ADAMTS1, and ADAMTS9 
were all increased in the granulosa cells during early ovulatory phase, as 
compared to preovulatory phase. In the theca cells, only MMP 19 was 
significantly increased in its expression. During the late ovulatory phase (18 to 
34 hours after the triggering of ovulation), there was still an increase in the 
expression of all four proteinases in the granulosa cell compartment. In the 
theca cell compartment, only MMP19 was still elevated, as compared to the 
preovulatory phase. During the postovulatory phase, only the theca cells were 
available for analysis, with results indicated that MMP19 showed a prolonged 
elevation. There were no changes seen in the expression of MMP and MMP13. 
In summary, the results reveal the rapid and early induction of MMP19 in both 
the theca and granulosa cells and that these elevated expression levels are 
sustained throughout the ovulatory process.  There was also the transient 
increased expression of MMP1, ADAMTS1, and ADAMTS9 during the early 
and late ovulatory phase, which was especially evident in the granulosa cell 
compartment. The results of messenger ribonucleic acid (mRNA) expression 
were mimicked by immunohistochemistry showing the localization of the 
proteins during ovulation. Two cell culture systems were used to examine the 
expression of the four different proteinases. Granulosa-lutein cells were pre-
cultured for 6 to 7 days to regain their responsiveness to human chorionic 
gonadotropin (hCG) after the receptor desensitization occurring after the hCG 
challenge in vivo, around 36 hours before oocyte pick-up. These cells 
responded in vitro to hCG via the expression of MMP1 and ADAMT 1, but no 
changes were observed for MMP19 or ADAMTS9.  Virally transformed 
granulosa cells, in order for an easily performed cell-culture with a large 
number of passages, have been used in research regarding ovarian physiology. 
In this study, we used 5HGL cells that are granulosa-like. Since the expression 
of the luteinizing hormone (LH) receptor might have been compromised, the 
cells were challenged with the direct stimulation of the LH-operative second 
messenger systems via forskolin and phorbol-12-myristate-13-acetate (PMA). 
Increased expressions of MMP1, ADAMTS1, and ADAMTS9 were observed 
but were of a lower magnitude than in the granulosa-lutein cells. 
 
Comments 
This study is one of the first to examine proteinase expression in the dominant 
preovulatory/ovulatory follicle of the natural menstrual cycle of women. The 
expression patterns of these four MMPs/ADAMTS found in the human are like 
those seen in previous studies on animal species, including detailed studies on 
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rat, mouse, and rhesus macaque. Thus, the results highlight that the function of 
these proteinases in ovulation is well preserved in mammalian ovulation.  
Studies on several different species have indicated that MMP1 is a key 
regulator in the breakdown of the follicle wall, and the results of the present 
study verified these observations. Expression of MMP1 in the granulosa cells 
increased more than 200-fold during the early ovulatory phase compared to the 
preovulatory phase and then declined during the late ovulatory phase. 
Expression in the granulosa cells was manifold higher than that in theca cells. 
These results indicate that this early mRNA expression with presumed protein 
expression verified by the immunohistochemistry experiments is important in 
the events of follicular rupture rather than in the tissue remodelling of the 
transition into a corpus luteum, which would reach its peak activity around and 
after follicular rupture. 
The other MMP that showed alterations in expression levels was MMP19. The 
expression of MMP19 increased in both the granulosa and theca cells, and, in 
comparison to MMP1, this high expression was more prolonged. Thus, 
increased expression was observed in the theca cells throughout ovulation and 
also during the postovulatory phase. This time course of this expression 
suggests that this MMP is important in the breakdown of ECM to accomplish 
follicular rupture and also in tissue remodelling during luteinisation.  
We evaluated the expression of two different ADAMTS in the human follicle 
during ovulation. This is the first study to explore these ADAMTS in human 
ovulation, with the assumption that ADAMTS also are important in human 
ovulation, as has also been shown before in rodent species. We found a 
pronounced increase in the expression of ADAMTS1 and ADAMTS9 in the 
granulosa cells, during both the early and late ovulatory phases, but no changes 
were seen in expression in the theca cells. The results strongly support the fact 
that the granulosa cell-derived production of these ADAMTS is important for 
ovulation to progress normally. 
In the present study, we used two different cell culture systems to examine if 
the in vivo situation could be mimicked in vitro. The experiments represent a 
start to the evaluation of systems that later could be used for studies on the 
regulation of expression and production of ovulatory mediators, such as 
proteinases. The results showed that the granulosa-lutein cells allowed to 
reverse to a LH-responsive state which is promising as a future tool for 
studying the intracellular regulation of ovulatory mediators. The virally 
transformed granulosa cells, albeit much easier to culture, were more 
questionable in this regard, since the expression showed fairly large differences 
compared to the in vivo situation.  
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Results and comments for Paper II 
During ovulation, there is a continued breakdown of the extracellular matrix 
(ECM) of the exterior wall of the preovulatory follicle so an oocyte can be 
released. Studies on several different species have shown that three families of 
proteases are likely to be instrumental in this process, which includes matrix 
metalloproteinases (MMPs), a disintegrin and metalloproteinase with 
thrombospondin motifs (ADAMTs), and the plasmin/PA families of proteases, 
which would then be instrumental in the breakdown of different collagens, 
laminin, and other ECM components in the two basement membranes 
(collagen type IV and laminin), the theca externa (mainly collagen type III), 
the external stroma of the ovary, and in the tunica albuginea (mainly collagen 
type I and III) that covers the top of the follicle that is on its way toward 
ovulation. The activation and regulation of these proteases are regulated by 
different inhibitors, and the delicate balance between these two variables is 
essential for site-directed ECM breakdown at the top of the follicle so that other 
parts of the follicle can be spared and the tissue integrity toward the basal part 
of the follicle maintained. This is most likely important in the smooth transition 
and remodelling of a ruptured follicle into a corpus luteum. One important 
protease inhibitor is tissue factor pathway inhibitor 2 (TFPI2), which belongs 
to the Kunitz family of serine protease inhibitors. The present study set out to 
determine the expression of TFPI2 in human and rat follicles during ovulation 
as well as to increase understanding of the regulation of this serine protease 
inhibitor in follicle cells during ovulation in humans. 
Expressions before and during different intervals of ovulation were compared 
in the human menstrual cycle and in a human chorionic gonadotropin (hCG)-
gonadotropin primed model of the immature rat. Cell culture experiments with 
interfering ribonucleic acid (RNA) were used, and assays for the quantification 
of messenger ribonucleic acid (mRNA), plasmin activity, cell viability, and 
steroid levels were applied.  
 
Results 
It was observed that the ovulatory trigger hCG induced the expression of 
TFPI2 in both cell compartments (granulosa and theca) of the ovulatory 
human follicle as well as in the entire ovulatory rat ovary, which mainly 
contains of large ovulating follicles due to their hyperstimulation by 
gonadotropin priming, which was induced during the prepubertal stage. In 
humans, a massive (around 2000-fold) induction of TFPI2 was seen in the 
granulosa cells during the early ovulatory phase, and, at this stage, the 
increase in theca cells was around 35-fold. In both cell compartments, TFPI2 
expression was maintained over the late ovulary phase and declined after 
ovulation. In the rat, with an ovulatory time span of around 12 hours (h), the 
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increase in TFPI2 expression 8 h after hCG was just below 200-fold and, at 
24 h post hCG, the levels had declined to those observed before the triggering 
of ovulation. The regulation of TFPI2 was studied in rat granulosa cells 
obtained before the ovulatory trigger. In these experiments, hCG triggered 
TFPI2 expression and directed the activation of protein kinase A (PKA) and 
protein kinase C (PKC) via forskolin, Phorbol-12-myristate-13-acetate 
(PMA) also induced TFPI2 expressions. The signalling pathways that are 
operative in gonadotropin-mediated TFPI2 expression were explored using 
pharmacological agents that inhibit the second messengers PKA and PKC as 
well as down-stream mitogen-activated protein kinase (MAPK) signalling. 
The results indicated that PKA, mitogen-activated protein kinase kinase 1/3 
(MEK1/3), and p38MAPK are important in the mediation of the signal to 
achieve TFPI2 production in granulosa cells. Additional experiments 
concerning the regulation of TFPI2 expression indicated the roles of the 
epidermal growth factor (EGF) receptor and the protease-activated receptor 1 
(PAR1) but not of signals mediated by progesterone or prostaglandins. The 
role of TFPI2 in the regulation of plasmin activity was observed in the cell 
culture experiments, utilizing small interfering RNA (siRNA) against TFPI2. 
To establish a broader picture of the downstream function of TFPI2, a TFPI2-
knockdown approach with siRNA and combination microarray analysis was 
used. Several genes were found to be down-regulated, and the results were 
confirmed by a real time polymerase chain reaction (RT-PCR), such as for 
amphiregulin (AREG) and interleukin 6 (IL6).  
Comments 
The study made use of a combination of experiments on both the human and 
the rat, which is the species that is most well-studied in terms of ovarian 
physiology, especially the regulation of ovulation. We report, for the first time, 
a marked increase in the expression of TFPI2 in the theca and granulosa cells 
of the ovulatory human follicle during the natural menstrual cycle as well as in 
the rat ovary. Moreover, we also examined the mechanisms involved in TFPI2 
expression and found that PKA, EGFR, MEK1/3, p38MAPK, and PAR-1 are 
important in signalling. Further studies will be able to highlight the exact 
mechanisms involved in this regulation. 
The cellular knock-down experiments clearly showed that TFPI2 influences a 
great number of pathways that’s implicated in ovulation and that play roles 
both in proteolytic degradation, vascular changes, and the expansion of the 
cumulus granulosa cells around the oocyte. Thus, TFPI2 plays a central role in 
ovulation, although its regulation is not mediated by progesterone-
progesterone receptor (PR) interaction, which is regarded as the main pathway 
for ovulation regulation. The reasons could be that TFPI2 will affect the 
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proteolytic processing of the growth factors, thereby affecting the gene 
expression of several mediators with growth-factor-dependent expression. 
In conclusion, the data supports the fundamental role of TFPI2 in remodelling 
ECM during ovulation as well as in the regulation of the expression of para-
/autocrine ovulatory mediators. 
 
Results and comments for Paper III 
Most studies within the ovulation field have investigated the roles of specific 
molecules involved in ovulation using in vivo experiments, in vitro perfusion 
experiments, cell cultures, or a molecular biology analysis of tissues/samples. 
The molecular biology approach has, in general, been used to analyse 
messenger ribonucleic acid (mRNA) expression via a quantitative real time 
polymerase chain reaction (RT-PCR) to acquire data on the regulation of 
certain genes, signalling pathways, or down-stream events after the 
perturbation of specific pathways. Studies on this aspect has used isolated 
granulosa and theca cells of species with larger follicles (e.g., human, monkey, 
bovine) as well as whole ovarian cell extracts from rodents with follicle sizes 
that do not allow for the separation of these cell compartments. To get closest 
to the roles of any mediator, it is of value to focus on protein levels. This can 
be applied by using a western blot technique for protein extracts from 
cells/tissues; however, drawbacks include the fact that these kind of 
experiments require a substantial amount of cells/tissue, since their sensitivity 
to quantitate proteins, in relation to a microarray and RT-PCR, in addition to 
their amplifying techniques for quantitating mRNA, is so much lower. 
Immunohistochemistry is a classical technique to detect proteins in tissues, but 
this methodology does not allow for the accurate quantification of protein 
levels. 
In large species, including primates, it is possible to obtain follicular fluid from 
larger follicles. The fluid-filled antrum develops from the early antral stage of 
the follicle and will then expand during later stages of folliculogenesis. It 
constitutes a major part of the microenvironment for the oocyte, cumulus cells, 
and the non-mural granulosa cells of the follicle wall. Via the modern 
proteomic approach, which is based on mass spectrometry, it is possible to 
identify and quantify many proteins in a small volume of a liquid sample. Prior 
to the present study, there existed some reports on the proteomic analysis of 
follicular fluid from in vitro fertilization (IVF) cycles in addition to 
comparisons at earlier stages. However, since the follicular fluid that is 
analysed is from an artificial hyperstimulated cycle, there will probably be 
deviations in protein regulation between these IVF cycles and ovulation during 
the human natural menstrual cycle. 
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The present study aims to examine the full protein content of human follicular 
fluid during natural ovulation. We used modern mass spectrometry with 
isobaric tags for relative and absolute quantification. This was applied to 
follicular fluid from the preovulatory phase and ovulatory phase.  
 
Results 
We identified over 500 proteins in the follicular fluid of the periovulatory 
interval, and 115 of these proteins were found in all the samples. Differences 
in abundance between the preovulatory phase and ovulatory phase were 
observed for 25 proteins, with most of these proteins being up-regulated during 
ovulation. The up-regulated proteins belonged to the biological processes of 
inflammation, coagulation, lipid metabolism, complement activation, and 
antioxidation.  The five proteins that were down-regulated during ovulation 
were enzymes or involved in lipid metabolism or iron transport. 
 
Comments 
This study is the first to analyse the proteomic profile of human follicular fluid 
in a near state of physiological ovulation. Its difference from the physiologic 
state is that ovulation was triggered by human chorionic gonadotropin (hCG) 
rather than by the natural, mid-cyclic peak of luteinizing hormone (LH). In this 
unique biological material from the follicular fluid of the human natural 
menstrual cycle, over 500 proteins were identified. Notably, proteins that 
showed changes in the level of follicular fluid during ovulation may play 
functional roles in this process. Out of the 20 upregulated proteins, several had 
previously been identified as ovulatory mediators or having the potential as 
such. Thus, it is well described that ovulation has many similarities to 
inflammation, and the present study also identified several of these proteins 
being upregulated. Some new biological pathways, such as coagulation and 
complement activation, were also indicated by the results of the present study 
as being operative in ovulation. Furthermore, in vitro studies combined with in 
vivo experiments of animals may highlight the exact mechanisms behind the 
action for these mediators. It is known that the complement system plays a role 
in the innate immune system, and it may be that this component of immune 
regulation is essential in the biologically important process of ovulation.  
A limitation of this study was the low number of individual samples, and it 
could be that this is not representative of a larger population or that other 
significant differences would be observed if the population was larger. 
However, it was cumbersome to acquire this biological material, with over 50 
women being screened for possible admittance into the study; thus, we do not 
predict that a similar larger study will be conducted in the near future, and we 
should therefore use the information on proteins produced by the present study 
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and combine this data with results from other studies examining mRNA 
expression, samples of IVF populations, and studies on non-human primate 
species.  
In conclusion, this study has, for the first time, examined the proteome profile 
of human follicular fluid during ovulation. Data on certain proteins may be 
essential in other scientific studies and to ultimately increase understanding of 
the human ovulatory process, which may provide clinically valuable 
information concerning anovulation, luteinized unruptured follicle syndrome, 
and the development of female contraceptives that could directly target the 
ovary.  
 
Results and comments Paper IV 
The number of potential ovulatory mediators is continuously expanding due to 
results from microarrays and proteomic studies that has identified several new 
products that are upregulated during ovulation in terms of messenger 
ribonucleic acid (mRNA) or protein levels. The studies have also exemplified 
new potential pathways that may be operative. Moreover, we had indications 
from microarray data that osteoprotegerin (OPG) and the receptor activator of 
nuclear factor kappa B ligand (RANKL) mRNA were present in human 
follicles during ovulation and that there was a variation in their expressions 
during the ovulatory interval. These proteins have never been linked to 
ovulation, but rather associated to bone physiology, specifically to the 
osteoblast. The usual role of OPG is to be a decoy receptor for RANKL, which 
will thereby decrease the binding of RANKL to the proper receptor activator 
of the nuclear factor kappa B (RANK). The molecular triad of OPG-RANKL-
RANK has later been linked to physiological events in endocrine organs, such 
as the thyroid gland, as well as in muscular organs (e.g., heart) and immune 
organs (e.g., spleen). A connection to the ovary is that OPG is induced by 
oestradiol and chemokines, which are major ovary-derived substances emitted 
before and during ovulation, respectively. 
Moreover, there is a link between alterations in the molecular triad of OPG-
RANKL-RANK and atherosclerosis, which is an inflammatory type of disease. 
Thus, since ovulation is parallel to inflammation in many mediator systems, 
this OPG-RANKL-RANK system may play a functional role in human 
ovulation. 
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Results 
The study used synthesized complementary deoxyribonucleic acid (cDNA) 
from extracted mRNA obtained from separated granulosa and theca cells, 
which were obtained during four distinct phases of ovulation of the natural 
menstrual cycle. In human granulosa cells, the mRNA levels of OPG showed 
a late increase during ovulation, with low levels during early ovulation and a 
2000-fold increase over the preovulatory stage and late ovulatory phase, 
corresponding to 18 to 34 hours (h) after human chorionic gonadotropin 
(hCG). The increased expression of OPG persisted during the period of 
luteinisation, with a 1000-fold increase during the postovulatory stage. The 
time-pattern of OPG expression in the theca cells was similar but of a lower 
magnitude.  
The expression of RANKL showed an early onset with significantly already 
increased levels in both the granulosa and theca cells during the early ovulatory 
stage. The magnitude of increase was around 10-fold higher in the granulosa 
cells compared to the theca cells. 
We also examined whether there would be variations in the serum levels of 
OPG and RANKL during the different reproductive phases. Minor variations 
were seen during the menstrual cycles, and the serum levels of OPG and 
RANKL were stable during breastfeeding and after menopause, with 
substantially lower levels in postmenopausal women than their fertile 
counterparts. 
 
Comments 
This study is the first study on any species to examine the expression of OPG 
and RANKL in the ovary. The marked increase of both mediators with slightly 
different expression profiles in time suggests that they both play roles in 
ovulation. The early expression of RANKL, prior to the increase in OPG, 
would suggest the major activity of RANKL during the first early and 
midovulatory events, considering that there will be some time for the mRNA 
to be transcribed into the protein as well as for the release of the protein from 
intracellular sources.  
Functional studies need to be performed on the expression and roles of OPG 
and RANKL in the follicle during ovulation. The preferred research setting for 
such experiments should be in the rat, considering the large extent of 
accumulated knowledge on ovulation in this species. Experiments could be 
performed with well-established in vitro perfusion techniques, in which 
pharmacological blockers or neutralizing antibodies could be administered 
with subsequent add-backs as positive controls. This system takes in account 
the near physiological situation of intact tissue architecture and communication 
between cells, since it is preserved.  
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A limitation of this study was that further quantification on the protein level 
was not performed, which was due to a lack in biological material with 
extracted proteins.  
Another way for detecting protein is immunohistochemistry, in which 
antibodies against specific proteins are applied on tissue sections. The present 
study, still in manuscript form, would benefit from this method of protein 
detection for OPG and RANKL, which will also allow for the examination of 
the distribution within the tissues. We are also aware of the limited number of 
samples per observation point during ovulation as well as the small number of 
participants in the three different groups of women that were examined for 
blood levels. 
In conclusion, this study has, for the first time, demonstrated the expression of 
two new potential mediators of ovulations. It is quite likely that the OPG-
RANKL-RANK system is operative in tissue remodelling in conjunction with 
ovulation, which is in line with the role of the system in bone tissue 
remodelling. Future studies should be performed to examine the functional 
aspects of this system within the ovary. 
 
Results and comments Paper V 
It is becoming more common for women on immunosuppressive medication 
following an organ transplantation to attempt to become pregnant. Most young 
women that have undergone organ transplantation and later will attempt 
pregnancy are those with kidney grafts, but there is also increasing numbers of 
young patients that have undergone transplantation of either the heart, lung, or 
liver. Uterus transplantation is a new modality of organ transplantation, with 
the target group so far only being women of fertile age. The basis of modern 
immunosuppression is the use of calcineurin inhibitors, with cyclosporine-A 
being the standard with an increasing global use in the last decade, in addition 
to the alternative calcineurin inhibitor tacrolimus. Any of these 
immunosuppressive agents are used in 95% of all solid organ transplant 
recipients. Several reproductive functions of both males and females are driven 
by immune cells, which work in close cooperation with the somatic cells of a 
specific organ. Thus, ovulation has many similarities with the traditional local 
inflammatory reaction, and several subtypes of leukocytes have been shown to 
play active roles in this process. There exist limited data on the effect of 
calcineurin inhibitors on reproductive processes such as ovulation. 
Additionally, animal studies have suggested the negative effects of calcineurin 
inhibitors on implantation; however, studies on their effects on ovulation are 
currently lacking. The aim of the present study was to examine the effect of 
the two calcineurin inhibitors, cyclosporine-A and tacrolimus, on ovulation 
with a well- characterized, gonadotropin-primed, immature rat model used as 
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the research tool. The immunosuppressive agents were administered at a 
constant rate by mini-osmotic pumps to achieve stable blood concentrations 
that would be similar to the human situation. A sham-operated group with 
saline-containing mini-osmotic pumps was used as the control group. 
 
Results 
The levels of cyclosporine-A and tacrolimus in the respective groups were 
within the therapeutic levels, which did not alter the peripheral count of any 
leukocyte examined. There was a clear decrease in the ovulation rate of the 
group treated with cyclosporine-A, but a similar ovulation rate was seen in the 
rats treated with tacrolimus and the controls. There were indications that both 
of the calcineurin inhibitors affected the ovulatory influx of neutrophils, since 
the expression of myeloperoxidase, which is a neutrophil-derived enzyme, 
decreased in both these groups as compared to controls. However, the other 
neutrophil-specific marker that was used, neutrophil-expressed elastase, did 
not significantly change, although its tendency to decrease was observed in the 
tacrolimus group. We used two well-known ovulatory mediators and measured 
the expression levels of the three groups. There was a decreasing tendency for 
the transcriptional regulator runt-related transcription factor 2 (RUNX2) in the 
group treated by tacrolimus. The distribution and density of the macrophages 
and T-cells were evaluated via immunohistochemistry examining newly 
formed corpora lutea. No difference in the densities of these subsets of 
leukocytes were observed for the newly formed corpora lutea.  
 
Comments 
This study is, to our knowledge, the first to examine the effect of calcineurin 
inhibitors on ovulation in any species. This is surprising since cyclosporine has 
been used in clinical transplantation for more than four decades and that organ 
transplantation among the fertile age group is becoming more common. Today, 
throughout the world, around 20% of all patients with solid organ transplants 
are of fertile age. Moreover, currently, tacrolimus, which comes in a once daily 
dosage, has been increasingly used, since some studies have indicated a 
somewhat better organ survival effects as compared to cyclosporine. The 
applied gonadotropin-primed animal model is well characterized in terms of 
the events of ovulation. The ovulation rate was only depressed after the 
administration of cyclosporine-A, and, after tacrolimus treatment, a normal 
ovulation rate was observed. This is reassuring, since tacrolimus is gaining 
more of the market share in solid organ transplantation. We measured several 
possible effectors on ovulation. Specifically, there was a decrease in the 
myeloperoxidase expression. This would indicate the lower density of the 
neutrophils or that the neutrophils expressed less of this enzyme.  
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Further studies should be conducted to examine the effects on the ovulation 
rate as well as ovulatory mediators with wider dose ranges for the calcineurin 
inhibitor. Another limitation of the study is that we studied the effects on a 
rodent species with the aim to extrapolate these results to the human situation. 
Even though most aspects of ovarian physiology show many similarities 
between humans and rats, there are large differences in the lengths and changes 
of the ovarian cycle, a rat has an ovulatory interval that, in length, is less than 
half that of a human. Thus, at a later stage, it would be preferable to expand 
these studies to also include a large mono-ovulatory species, such as a non-
human primate. Another aspect is that it is likely that a large proportion of the 
transplanted women of fertile age will need assisted reproduction with in vitro 
fertilization (IVF) to become pregnant, which is also true for those with uterus 
transplantations in which the oviducts are excluded in the graft. Any 
disturbance in ovulation by the immune system would then be of less 
importance, but other aspects, such as risk of ovarian hyperstimulation 
syndrome, implantation, early placentation, and pregnancy, would have to be 
studied.  
In conclusion, the study, for the first time, showed that a calcineurin inhibitor 
exerts an inhibitory function on ovulation. The result may have implications 
for female patients with solid organ transplants aiming to become pregnant. 
Early examinations conducted to ascertain the occurrence of ovulation should 
then take place.  
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DISCUSSION 
The focus of this thesis is intra-ovarian mechanisms of ovulation, with special 
emphasis concerning the human ovulatory process. Data from this thesis may 
become essential in future studies and lead ultimately to detailed knowledge 
concerning the human ovulatory process and how disturbances can occur in 
this. This may provide us with clinical valuable information concerning 
anovulation, luteinized unruptured follicle syndrome, ovarian 
hyperstimulation syndrome (OHSS) as well as in the development of new 
strategies for female contraception, with direct action on the ovary. 
The studies described in this thesis outline a typical sequence of ovulatory 
changes. Ovulation is initiated by the luteinizing hormone (LH) surge, with the 
first responders being granulosa and theca cells. Both these cell types, express 
LH receptors, although at higher density in granulosa cells. Both these cell 
types produce cytokines, chemokines, prostaglandins, steroids, and other 
paracrine inflammatory mediators. These mediators activate resident immune 
cells and attract additional leukocytes. Proteases, which are produced by 
somatic ovarian cells and leukocytes, weaken the basement membrane 
between the granulosa cell compartment and the theca cell compartment. These 
proteases and the structural changes facilitate neoangiogenesis with invasion 
of vascular endothelial cells and additional immune cells. Traditional 
inflammatory mediators, in concert with follicle-specific stimuli, trigger 
cumulus expansion and the detachment of the cumulus oocyte complex from 
the basal granulosa cells. At the follicle apex, there is vascular constriction, 
detachment of cells, and extensive extracellular matrix (ECM) remodelling. 
The remainder of the follicle undergoes angiogenesis, functional 
differentiation of granulosa and theca cells, tissue remodeling, and contraction. 
Ultimately, these functional and structural changes culminate in both rupture 
when the tensile strength of the follicle can no longer hold back the fluid 
pressure inside the antrum.  
A main focus of the thesis is inflammation and the role of ECM degradation 
and regulation. As outlined in the Papers and the introduction several ECM 
components, mostly collagens, give the support and structure to the follicle. 
With use of new CLARITY technique it is evident how complex the ECM is 
arranged, in and around the follicle as well as for the vasculature of the ovary 
(Feng et al., 2017).The degradation of the ECM is a delicately balanced process 
and, with synthesis, activation, and regulation of the matrix metalloproteinases 
(MMPs), plasminogen activators (PAs), and a disintegrin and 
metalloproteinase with thrombospondin-like motifs (ADAMTS), as discussed 
in Paper I and II being essential. The ECM homeostasis, with all these 
components, is important in the ovary as well as in other organs Birkedal-
Hansen et al., 1993).  
Farnosh Zakerkish Sørensen 
46 
 
In this regard it should also be mentioned that osteoprotegerin (OPG) and 
receptor activator of nuclear factor kappa B ligand (RANKL), as examined in 
Paper IV, are important for ECM turnover and remodelling in bone tissue 
(Costa Fernandes et al., 2019). In Paper IV any further functional studies were 
not performed but the very high ovarian expression levels of these two 
components of this ligand-decoy receptor system suggests an active role in the 
tissue remodeling of ovulation. This is further discussed in Paper IV.  
Much literature is supporting and promoting a paramount role for MMPs in 
ovulation. As also described in the Introduction there is a morphological 
fragmentation of the collagenous matrix at the follicular apex (Bjersing & 
Cajander, 1971, Fukumoto et al., 1981). Moreover, biochemical methods 
found decreased collagen content in the follicle after the LH surge and this was 
most pronounced at the top of the follicle. It is likely that part of this 
degradation of the follicular ECM occur via the action of a cascade of 
proteolytic events such as MMPs (Paper I), plasmin (Paper II) and other 
inflammatory-related proteins (Paper III). Importantly, results of those papers 
were merely descriptive and naturally a functional role could not be elucidated 
in a safe study situation in the human. However, corroboration for a role of the 
MMPs system in follicular rupture is from animal studies where ovulation was 
inhibited by blocking MMP activity with chemical MMP inhibitors or blocking 
antibodies towards MMPs in the rat (Brännström et al., 1988), hamster 
(Gottsch et al.,2002), sheep (Ichikawa et al., 1983) and rhesus macaque 
(Peluffo et al., 2011). Naturally, the non-human primate species of the 
macaque is very close to the human concerning the reproductive anatomy and 
physiology, so results from this species could be extrapolated to the human. 
Moreover, as shown in Paper I, the expression profiles of MMPs in the human 
mimics that in the rhesus macaque although with some differences in specific 
MMPs as outlined below. Thus, studies from The Oregon group of Stouffer 
aspirated granulosa cells from the dominant follicle prior to human chorionic 
gonadotropin (hCG) administration (0 h) or 12, 24, or 36 h after hCG to 
examine messenger ribonucleic acid (mRNA) expression of MMP1, MMP2, 
MMP3, MMP7, MMP9, tissue inhibitor of metalloproteinase (TIMP)1, and 
TIMP2 (Chaffin & Stouffer, 1999). At the 12 h examination point 12 h after 
hCG, there was an increase in MMP1, MMP2, MMP7, TIMP1, and TIMP2. 
However, MMP9 mRNA did not increase until immediately prior to ovulation 
(Chaffin & Stouffer, 1999). In Paper I, we examined also the expression of 
MMP1 in granulosa cells but additionally also in theca cells. Although the 
interval from hCG to follicular rupture is similar (36-38 h) in the rhesus 
macaque and the human, we were only able to examine two time points (early 
ovulatory phase; late ovulatory phase). Moreover, the samples from the studies 
of this thesis (Papers I-IV) were not as exact on the hour in relation to the study 
by Stouffer (Chaffin & Stouffer, 1999). 
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Although the experimental design was somewhat similar, we could not 
schedule our sterilization surgeries on demand, out of logistic reason at the 
hospital but also from a patient and doctor perspective. Nevertheless, the 
human material we have acquired is to our knowledge unique since it is the 
first study where granulosa cells and theca cells have been obtained from the 
human natural menstrual cycle. In comparison, studies from the Copenhagen 
group, that also have looked at human ovulation, has used granulosa cells 
obtained before and after hCG in hyperstimulated in vitro fertilization (IVF) 
cycles (Wissing et al., 2014), and it is known from several comparative studies 
that the levels of mediators can differ markedly between these two settings of 
patients.  
Progesterone is an early key mediator in ovulation, where progesterone binding 
will cause further downstream signaling. In the study by Stouffer and 
coworkers one group of macaques were given an inhibitor of progesterone 
synthesis and another group received this treatment and add back of the non-
metabolizable progestin R5020 (Chaffin & Stouffer, 1999). Granulosa cells 
were examined at 12 and 36 h after hCG. The blockage of progesterone 
synthesis, and presumably progesterone receptor (PGR) activation, decreased 
mRNA levels for MMP1, MMP2, MMP7, TIMP1, and TIMP2, with 
demonstrated reversal for MMP1 and TIMP1by the non-metabolizable 
progestin R5020 ( Chaffin & Stouffer, 1999). This finding further points 
towards the importance of MMP1 in ovulation in primates, including the 
human. In Paper I, we found a very pronounced increase of MMP1 expression 
in granulosa cells during the early ovulatory phase and this increase in mRNA 
levels was 200-fold as compared to the preovulatory stage. A follow-up study 
from the same group also included other factors related to ADAMTS and PA 
systems, in addition to MMPs (Chaffin & Stouffer, 1999). There was an 
increase at 12 h for some MMPs (MMP1, MMP10, and MMP19) and 
ADAMTS (ADAMTS4, ADAMTS9, and ADAMTS15), as well as PLAU. 
After follicular rupture the mRNA levels MMP1, MMP10, MMP19, 
ADAMTS1, ADAMTS4, ADAMTS9, and urokinase-type plasminogen 
activator (PLAU) were elevated again, suggesting roles for some of them in 
ovulation and some of them in structural luteinization. 
It is more difficult to conduct these types of experiments in the human. In an 
attempt to get this precious material in order to get insight into human 
ovulation our group at Sahlgrenska methodically collected the dominant 
follicle before, during and after ovulation. In this clinical trial, where around 
50 women were initially participating the tissue was extracted from women 
operated laparoscopically for tubal sterilization. In this clinical study, women 
were monitored by serial transvaginal ultrasound (TVU) for around two cycles 
before surgery to determine if accurate follicular development occurred. 
During the menstrual cycle for the laparoscopic sterilization, ultrasound was 
Farnosh Zakerkish Sørensen 
48 
 
performed every 1–2 days to enable the surgery to be planned at the accurate 
stage of the menstrual cycle. The study population was randomly divided into 
four groups (pre-ovulatory phase, early ovulatory phase, late ovulatory phase 
and post- ovulatory phase) to distinguish between the different ovulatory 
stages. The ovulation trigger was hCG and the surgery was conducted in 
different phases, where the preovulatory phase was defined as the stage when 
the dominant follicle was >14 mm and <17.5 mm prior to hCG administration. 
The early ovulatory phase was defined as 12 to 18 hours after hCG, the late 
ovulatory phase was 18 to 24 hours after hCG and the postovulatory phase was 
44 to 77 h after hCG. At the time of surgery, the whole dominant follicle was 
excised, as schematically shown in Fig. 8 
Fig. 8. Type of ovarian excision to obtain material from periovulatory 
follicle. 
 
The material has been used for studies on extracellular matrix (Lind et al., 
2006), the gelatinases (Lind et al., 2006), the stromelysins (McCord et al., 
2012) and other MMPs and ADAMTS (Rosewell et al., 2015), as discussed 
below. 
Dissection of the dominant human follicle into the granulosa and theca cell 
compartments has provided additional data into ovulatory changes in the MMP 
system. In one study, the changes in the stromelysins (MMP3, MMP10, and 
MMP11) was examined across the periovulatory period (McCord et al., 2012). 
Expression of MMP10 mRNA was low in human granulosa and theca cells 
from follicles collected at the preovulatory phase. After ovulation trigger, there 
was a marked increase in the levels of MMP10 mRNA and the elevation 
remained at the late ovulatory phase. In theca cells, MMP10 mRNA levels 
returned to preovulatory levels by the postovulatory period. In contrast, levels 
of mRNA for MMP11 decreased to less than half of the preovulatory follicles, 
after ovulation triggering. 
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In Paper I, the expression of the major MMPs and ADAMTS were examined 
in the granulosa and theca cell compartments across the human periovulatory 
period. The ovulation trigger hCG elevated levels of mRNA for MMP1, 
MMP19, ADAMTS1, and ADAMTS9 in the granulosa cell compartment. 
There were differences in the temporal mRNA expression pattern of the 
diverse MMP and ADAMTS in granulosa cells that varied slightly among the 
proteinases with MMP1, ADAMTS1, and ADAMTS9 mRNA increasing 
during the early ovulatory period whereas MMP19 mRNA was increased 
during the late ovulatory period. For the other collagenases, MMP8 and 
MMP13 mRNA expression was extremely low and did not change throughout 
the periovulatory period in either granulosa or theca cells. In theca cells, 
MMP19 was the only proteinase that was induced by hCG, with mRNA 
expression increasing during the late ovulatory period and remaining elevated 
during the postovulatory period. Determining the localization of these 
proteinases revealed an overall general pattern with increased staining intensity 
present in the granulosa and theca cell layers after hCG administration. This 
immunohistochemistry result correlated with the observations of the mRNA 
expression.  
Follicular fluid can be used as one body fluid to detect changes in the ovary 
and especially in the closely situated granulosa cells, this was used in Paper 
III. Previously, MMP2 and MMP9 activity were detected in follicular fluid by 
gelatin zymography (D`Ascenzo et al., 2004, Nikolettos et al., 2003). 
Interestingly, in IVF follicular fluid the levels of gelatinase seemed to be higher 
for agonist cycles than for antagonist cycles of drug administration (Bilen eta 
al., 2014). One study compared the protein levels of MMP in the follicle 
between normally ovulating women and of patients undergoing ovarian 
hyperstimulation for IVF (D`Ascenzo et al., 2004). Lower MMP levels were 
found in follicular fluid of IVF patients compared with those of normally 
ovulating women, but the inverse relationship was seen for TIMP1.  
The PA system is also involved in ovulation and that was studied to some 
extent in Paper II. There are several studies proposing a role for this system in 
ovulation. Thus, in the rat, ovulation is preceded by a transient and cell specific 
expression of tissue-type plasminogen activator (PLAT) resulting in 
proteolytic activity localized to the surface of the ovary overlaying the 
ovulatory follicle prior to ovulation (Liu et al., 2013). In the rhesus macaque, 
exogenous hCG administration showed that granulosa cells are the major 
source of PLAT production, as reflected by changes in mRNA and proteolytic 
activity to facilitate the breakdown of the follicular wall to permit oocyte 
release (Liu et al., 2004). Studies in the human reported presence of low levels 
of PLAT mRNA and a lack of PLAU mRNA in IVF granulosa-lutein cells by 
Northern blot analysis in human granulosa cells collected from preovulatory 
follicles at the time of IVF (Jones et al., 1989, Weimer et al., 1984). In Paper 
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II, the regulation of plasmin activity by tissue factor pathway inhibitor 2 
(TFPI2) was studied in rat granulosa cells. The granulosa cells were stimulated 
by forskolin and phorbol 12-myristate 13-acetate (PMA). Interfering RNA to 
knockdown TFP12 showed increased plasmin activity, demonstrating the 
interplay between these two systems. 
In the present thesis, several aspects of ovulation and its relationship to 
inflammation has been explored. In Paper I dramatic changes in certain 
proteases were seen at ovulation in the human. Importantly, this increase in 
expression levels of proteases showed a temporal profile suggestive of 
participation in follicular rupture, rather than in later events. In Paper II it was 
demonstrated that the protease inhibitor TFPI2, which has a role in controlling 
inflammation, is also regulated by an ovulatory trigger. Several inflammatory 
mediators were regulated downstream of TFP12. Inflammatory mediators were 
also seen in higher follicular fluid levels in women at ovulation than before as 
shown in Paper III. Also, the OPG-RANKL system, as studied in Paper IV, 
has a role in inflammatory diseases such as arthritis and atherosclerosis. In 
Paper V of the present study, suppression of the immune system/inflammation 
by cyclosporine A decreased ovulation rate. Collectively, the results of this 
thesis further emphasize the similarities between the ovulation reaction and the 
inflammatory reaction. 
There may exist some clinical states with relevance to the results of the thesis. 
One is luteinized unruptured follicle (LUF) syndrome, which is defined as 
absence of follicle rupture and without release of an oocyte. This happens in 
the presence of a seemingly normal follicular growth in the follicular phase, 
normal endocrinology, and a normal span of the luteal phase. The most reliable 
diagnostic tool for LUF is repeated examinations with TVU, showing a 
growing follicle, normal follicle before ovulation and then no follicular 
collapse/ corpus luteum (Marik et al., 1978). The formation of LUF may be 
linked to dysregulation of the ovulation-associated inflammatory changes. 
Thus, the general cyclooxygenase inhibitor indomethacin change the 
vasculature of the preovulatory sheep follicles (Murdoch et al., 1989) in a 
similar manner as observed in LUF in women. Another, indication of a link 
between LUF and inflammation is in women previously diagnosed with LUF 
syndrome, an injection of the cytokine colony-stimulating factor just before 
hCG reduced the occurrence of LUF to 4% of the cycles as compared to 19% 
in those women not receiving the cytokine (Shibata et al., 2016). 
The findings of the present study may also have implications for diagnosis and 
treatment of ovarian hyperstimulation syndrome (OHSS). This is a 
pathophysiological state with massive inflammation and with signs of 
overexpression of several ovulatory mediators (Nastri et al., 2010). Several of 
these have been covered in the present thesis. 
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The fact that ovulation is inflammation-like in its mediation is also suggested 
by the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on ovulation. 
In a first study on this aspect the effect of two different non-selective 
prostaglandin synthase inhibitors (indomethacin or azapropazone) were 
compared regarding ovulation rate (Killick & Elstein, 1987). The incidence of 
LUF (10% in control cycles) in azapropazone or indomethacin cycles were 
50% and 100%, respectively. Normal steroid levels, also concerning 
progesterone were found in LUF cycles. A selective 
peroxidase/cyclooxygenase prostaglandin-endoperoxide synthase 2 (PTGS2) 
inhibitor was used in a study from Sahlgrenska, and the agent rofecoxib was 
given from midfollicular phase (Pall et al., 2001) even if ovulation was not 
inhibited, it was delayed by more than one day in almost 70% of the women. 
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